[
    {
        "src_smiles": "Cn1ccnc1SCC(=O)Nc1cccc([N+](=O)[O-])c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methylated pyridine ring connected through a thioether linkage to an amide group, which is further attached to a nitro-substituted phenyl ring. This structure incorporates aromatic rings, a thioether, and an electron-withdrawing nitro group, contributing to its overall complexity.",
            "Property Analysis": "The molecule exhibits reasonable drug-likeness based on its QED score, with balanced molecular weight and acceptable lipophilicity. However, the presence of the nitro group increases polarity and may negatively impact solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "The nitro substituent introduces excessive polarity and potential toxicity, which detracts from the molecule's overall QED and drug-likeness, making it less favorable for drug development.",
            "Optimization for Source Molecule": "Replace the nitro group with a less polar and less toxic moiety, such as a trifluoromethyl group, to enhance lipophilicity, reduce polarity, and improve the QED score while maintaining the structural framework.",
            "Final Target Molecule": "Cn1ccnc1SCC(=O)Nc1cccc(C(F)(F)F)c1"
        }
    },
    {
        "src_smiles": "O=C(O)c1cn(COCCO)c2ccc([N+](=O)[O-])cc2c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a bicyclic structure comprising two fused rings. It includes a pyrimidine core with two carbonyl groups, a diethylene glycol ether substituent (COCCO), and a nitro group attached to the aromatic ring. The molecule possesses multiple polar functional groups which contribute to its solubility and hydrogen bonding capabilities.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness (QED) due to its balanced molecular weight, hydrogen bond donors and acceptors, and reasonable lipophilicity. The presence of both polar and non-polar regions supports bioavailability, while the aromatic system may facilitate specific molecular interactions.",
            "Limitation in Source Molecule for Property": "The nitro group present in the molecule can lead to potential toxicity and metabolic instability, negatively impacting its drug-likeness. Additionally, the diethylene glycol ether moiety may increase molecular weight and polarity excessively, potentially hindering membrane permeability and oral bioavailability.",
            "Optimization for Source Molecule": "To enhance QED, the nitro group can be replaced with a less toxic and more metabolically stable functional group, such as an amino or hydroxyl group. The diethylene glycol ether substituent can be modified to a shorter chain or replaced with a bioisostere to reduce molecular weight and improve membrane permeability. Introducing minor modifications to enhance lipophilicity without compromising solubility may also be beneficial.",
            "Final Target Molecule": "O=C(O)c1cn(COC)c2ccc(N)cc2c1=O"
        }
    },
    {
        "src_smiles": "CCOC(=O)c1cnc2ccnn2c1SCC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features an ethoxycarbonyl group (CCOC(=O)-) connected to a fused heterocyclic system. The core structure consists of a pyrimidine ring fused with an imidazole ring, further fused to a triazole ring, creating a polyheterocyclic framework. Additionally, there is a thioether linker (SCC) attached to the fused ring system, introducing sulfur atoms into the structure.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) of the source molecule is influenced by its molecular weight, lipophilicity, number of hydrogen bond donors and acceptors, and overall structural complexity. The molecule possesses multiple heteroatoms (nitrogen and sulfur) which can enhance bioactivity and solubility. However, the presence of the ethoxycarbonyl group and the multiple ring systems may contribute to increased lipophilicity and molecular weight, potentially impacting its drug-like properties.",
            "Limitation in Source Molecule for Property": "The primary limitations affecting the QED of the source molecule include high lipophilicity due to the ethoxycarbonyl group and the thioether linker, which can lead to poor solubility and bioavailability. Additionally, the molecular weight may exceed optimal ranges for drug-likeness, and the complexity of the fused heterocyclic system could pose challenges in synthesis and metabolic stability.",
            "Optimization for Source Molecule": "To enhance QED, the molecule can be optimized by reducing lipophilicity and molecular weight. This can be achieved by modifying the ethoxycarbonyl group to a less lipophilic ester or removing it altogether. Simplifying the thioether linker by reducing the number of carbon atoms can also decrease lipophilicity. Furthermore, introducing polar functional groups may improve solubility and adherence to Lipinski's rule of five. Streamlining the fused heterocyclic system to maintain essential bioactive features while reducing complexity can also contribute to improved drug-likeness.",
            "Final Target Molecule": "CCOC(=O)c1cnc2ccnn2c1SC"
        }
    },
    {
        "src_smiles": "C=CCSc1cc(C)nc2c(-c3ccccc3)c(C)nn12",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a vinyl sulfide moiety (C=CCS) attached to a bicyclic system. The bicyclic structure includes a thiophene ring fused with a pyrimidine ring, which is substituted with a methyl group. Additionally, there is an aniline moiety connected to a phenyl ring, and the nitrogen atoms form a triazine-like structure within the bicyclic system.",
            "Property Analysis": "The molecule exhibits moderate molecular weight and lipophilicity, contributing positively to its QED (drug-likeness). However, the presence of multiple nitrogen heterocycles and sulfur may affect its solubility and permeability. The compound also contains aromatic rings, which enhance binding properties but may increase synthetic complexity.",
            "Limitation in Source Molecule for Property": "High lipophilicity due to multiple aromatic and heteroaromatic rings can lead to poor aqueous solubility and potential off-target interactions. The presence of sulfur and multiple nitrogen atoms may also pose challenges for metabolic stability and increase the risk of toxicity. Additionally, the extended conjugation might hinder the compound's compliance with Lipinski's rule of five.",
            "Optimization for Source Molecule": "To improve QED, the molecule can be optimized by reducing lipophilicity through the introduction of polar functional groups or by modifying existing aromatic rings to reduce their size. Replacing the sulfur atom with a less lipophilic heteroatom such as oxygen or nitrogen could enhance solubility. Additionally, simplifying the bicyclic system to decrease molecular complexity and conforming more closely to Lipinski's rules can enhance drug-likeness.",
            "Final Target Molecule": "C=COCSc1cc(C)nc2c(-c3ccccc3)c(C)nn12"
        }
    },
    {
        "src_smiles": "COCCSc1nnc(NC(=O)CSc2ccccc2)s1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, COCCSc1nnc(NC(=O)CSc2ccccc2)s1, consists of a thioether-linked bicyclic structure. It has a central five-membered ring containing two nitrogen atoms (1,2,3-triazole or a similar aromatic ring), connected through sulfur (S) atoms to ethoxy (OCCO) groups and to a thiocarbonyl (NC(=O)C) moiety attached to a phenyl ring (c2ccccc2). The presence of multiple sulfur atoms, aromatic rings, and ether linkages contributes to the molecule's overall structure and properties.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) assesses various molecular properties to predict the likelihood of a compound being a viable drug candidate. The source molecule has several characteristics favorable for drug-likeness, including aromatic rings and hydrogen bond acceptors. However, the molecule also contains multiple sulfur atoms and ether linkages, which may negatively impact its solubility and metabolic stability, potentially lowering its overall QED score.",
            "Limitation in Source Molecule for Property": "The primary limitations affecting the QED of the source molecule include the presence of multiple sulfur atoms, which can contribute to poor metabolic stability and potential toxicity. Additionally, the ether linkages may reduce the molecule's solubility and increase the risk of metabolic degradation. These factors can diminish the overall drug-likeness of the compound.",
            "Optimization for Source Molecule": "To improve the QED of the source molecule, the following optimization steps can be undertaken:\n1. **Reduce Sulfur Content**: Replace some of the sulfur atoms with oxygen or nitrogen to enhance metabolic stability and reduce potential toxicity.\n2. **Improve Solubility**: Introduce polar functional groups or reduce the number of hydrophobic aromatic rings to increase aqueous solubility.\n3. **Simplify the Structure**: Remove or alter excessively complex linkages to improve synthetic accessibility and reduce molecular weight.\n4. **Enhance Hydrogen Bonding**: Add more hydrogen bond donors or acceptors to improve binding interactions with biological targets.\n5. **Optimize Lipophilicity**: Adjust the balance between hydrophobic and hydrophilic regions to achieve optimal lipophilicity, enhancing membrane permeability and bioavailability.",
            "Final Target Molecule": "COCCOc1nnc(NC(=O)CSc2ccccc2)s1"
        }
    },
    {
        "src_smiles": "O=C1NC(=O)C(=Cc2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a bicyclic structure comprising a lactam ring fused to a sulfonamide-linked aromatic system. It contains multiple aromatic rings, a nitro group, and both carbonyl and sulfonyl functional groups, contributing to its rigidity and potential electronic properties.",
            "Property Analysis": "The molecule has a high Quantitative Estimate of Drug-likeness (QED) due to its balanced molecular weight, presence of hydrogen bond donors and acceptors, and aromatic systems which are favorable for bioactivity. However, the multiple aromatic rings and electron-withdrawing groups may increase lipophilicity and reduce solubility.",
            "Limitation in Source Molecule for Property": "Excessive lipophilicity from multiple aromatic rings and electron-withdrawing groups can negatively impact solubility and bioavailability. Additionally, the presence of a nitro group may raise concerns regarding metabolic stability and toxicity.",
            "Optimization for Source Molecule": "Simplify the aromatic system by reducing the number of aromatic rings, replace the nitro group with a less electron-withdrawing and metabolically stable substituent, and introduce polar functional groups to enhance solubility and reduce lipophilicity.",
            "Final Target Molecule": "O=C1NC(=O)C(Cc2ccccc2)S1"
        }
    },
    {
        "src_smiles": "O=C(CCCCCCC(=O)Nc1ccccc1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, represented by the SMILES string O=C(CCCCCCC(=O)Nc1ccccc1)NO, consists of a central diketone structure with a seven-carbon alkyl chain. Attached to one of the carbonyl groups is a phenylhydroxylamine moiety (Nc1ccccc1), and to the other carbonyl group is a hydroxylamine (NO) group. This structure features both amide and hydroxylamine functional groups connected to aromatic rings, contributing to its overall complexity.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) for the source molecule is likely suboptimal. Factors such as a long alkyl chain, multiple hydrogen bond donors and acceptors, and the presence of both amide and hydroxylamine groups may negatively impact its drug-likeness by increasing molecular weight and lipophilicity beyond ideal ranges.",
            "Limitation in Source Molecule for Property": "The molecule's extended seven-carbon alkyl chain contributes to high lipophilicity and molecular weight, which can reduce solubility and bioavailability. Additionally, multiple hydrogen bond donors and acceptors can lead to excessive polarity, further hindering membrane permeability and drug-likeness.",
            "Optimization for Source Molecule": "To enhance the QED of the molecule, the long alkyl chain should be shortened or replaced with a more compact moiety to reduce molecular weight and lipophilicity. Simplifying the functional groups by retaining only one hydrogen bond donor or acceptor can decrease polarity. Introducing heteroatoms or bioisosteres to replace bulky groups may also improve drug-like properties without compromising biological activity.",
            "Final Target Molecule": "O=C(CCC(=O)Nc1ccccc1)NO"
        }
    },
    {
        "src_smiles": "CON(C)C(NC(C)=O)C(=O)NCc1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, CON(C)C(NC(C)=O)C(=O)NCc1ccccc1, consists of a central carbon connected to a dimethylamino group (CON(C)), a secondary amide linkage (C(NC(C)=O)), another amide group (C(=O)NC), and a benzyl aromatic ring (Cc1ccccc1). This structure features multiple amide functionalities and an aromatic moiety, contributing to its complexity and potential hydrogen bonding capabilities.",
            "Property Analysis": "The molecule exhibits a moderate QED (Quantitative Estimate of Drug-likeness) score. While the presence of aromatic rings and amide groups can enhance binding interactions, the molecule may suffer from poor solubility and high lipophilicity due to the benzyl group and multiple amide linkages. Additionally, the molecule has several hydrogen bond donors and acceptors, which can affect its pharmacokinetic properties.",
            "Limitation in Source Molecule for Property": "The high number of hydrogen bond donors and acceptors, along with increased lipophilicity from the benzyl group and multiple amide bonds, may negatively impact the drug-likeness of the molecule. These factors can lead to poor bioavailability, increased metabolic liabilities, and challenges in achieving optimal pharmacokinetic profiles.",
            "Optimization for Source Molecule": "To enhance the QED property, the molecule can be optimized by reducing lipophilicity and the number of hydrogen bond donors and acceptors. This can be achieved by modifying or removing the benzyl aromatic ring to decrease lipophilic character and simplifying the amide linkages to reduce hydrogen bonding potential. Introducing polar yet drug-like functional groups and maintaining structural simplicity can improve solubility and overall drug-likeness.",
            "Final Target Molecule": "CC(NC(C)=O)C(=O)NCc1ccccc1"
        }
    },
    {
        "src_smiles": "O=C(C=Cc1ccc(C(=O)c2ccc3ccccc3n2)cc1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a nitroso-substituted vinyl ketone connected to a substituted benzene ring, which is further linked to a fused benzene-pyridine system. Key functional groups include the ketone, nitroso moiety, and multiple aromatic rings, contributing to its structural complexity and potential biological activity.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness with a QED score below optimal thresholds. It possesses multiple aromatic systems and polar functional groups, which may influence its solubility, permeability, and overall pharmacokinetic properties. The presence of the nitroso group can also impact its stability and reactivity.",
            "Limitation in Source Molecule for Property": "The extensive aromatic system increases molecular rigidity and size, negatively affecting solubility and bioavailability. Additionally, the nitroso functional group may introduce undesired reactivity and potential toxicity, limiting the molecule's suitability as a drug candidate.",
            "Optimization for Source Molecule": "To improve the QED, the molecular complexity can be reduced by minimizing the number of aromatic rings. Replacing the nitroso group with a less reactive and more biocompatible functional group, such as an amine or hydroxyl group, can enhance stability and reduce toxicity. Introducing polar substituents may also improve solubility without significantly increasing molecular weight.",
            "Final Target Molecule": "O=C(C=Cc1ccc(C(=O)c2ccc3ccccc3n2)cc1)N)O"
        }
    },
    {
        "src_smiles": "O=C(O)CN1C(=O)SC(=Cc2cccc([N+](=O)[O-])c2)C1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a dicarbonyl structure linked to a heterocyclic ring. It contains an amino acid moiety (O=C(O)CN), a thioamide functional group (C(=O)S), and an aromatic ring substituted with a nitro group ([N+](=O)[O-]). The molecule features multiple polar functional groups, including carbonyls, amine, and nitro groups, contributing to its overall polarity and hydrogen-bonding capacity.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) evaluates the drug-like properties of a molecule based on factors such as molecular weight, lipophilicity (LogP), number of hydrogen bond donors and acceptors, and the presence of certain structural features. The source molecule has moderate QED due to its balance of hydrophilic and hydrophobic regions but may be limited by its high polarity and presence of multiple hydrogen bond donors and acceptors.",
            "Limitation in Source Molecule for Property": "The high polarity arising from multiple carbonyl groups, amine functionalities, and the nitro-substituted aromatic ring increases the molecule's hydrophilicity, potentially reducing its membrane permeability and oral bioavailability. Additionally, the presence of the nitro group may raise concerns regarding metabolic stability and toxicity, which could negatively impact the QED.",
            "Optimization for Source Molecule": "To improve the QED, modifications should aim to reduce molecular polarity and enhance lipophilicity without compromising solubility excessively. This can be achieved by: \n1. Replacing the nitro group with a less polar substituent, such as a cyano or trifluoromethyl group, to decrease polarity and maintain electron-withdrawing properties.\n2. Introducing a methyl or other alkyl groups to reduce the number of hydrogen bond donors and acceptors, thereby improving membrane permeability.\n3. Simplifying the heterocyclic ring system to reduce molecular complexity and potential metabolic liabilities.",
            "Final Target Molecule": "O=C(O)CN1C(=O)SC(=Cc2cccc(C(F)(F)F)c2)C1=O"
        }
    },
    {
        "src_smiles": "O=C(CCCc1ccc(CCCCc2ccccc2)cc1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a ketone group linked to a propyl chain, which is attached to a substituted benzene ring. The benzene ring is further substituted with a butylated phenyl group. Additionally, there is a nitroso functional group attached to the ketone.",
            "Property Analysis": "The molecule has moderate drug-likeness (QED) due to the presence of multiple aromatic rings, which contribute to its lipophilicity. The nitroso group may affect its stability and biological activity.",
            "Limitation in Source Molecule for Property": "High lipophilicity from multiple aromatic rings can lead to poor solubility and bioavailability. The nitroso group may also pose challenges in terms of metabolic stability and potential toxicity.",
            "Optimization for Source Molecule": "Reduce lipophilicity by modifying or reducing the number of aromatic rings. Replace the nitroso group with a more stable and less reactive functional group, such as an amine or hydroxyl group, to enhance metabolic stability and reduce toxicity.",
            "Final Target Molecule": "O=C(CCCc1ccc(CCO)c(C)c1)N"
        }
    },
    {
        "src_smiles": "C#CCCCC(=O)c1cc2c(c(C(C)(C)C)c1)OCC2",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises an alkyne moiety (C#C) connected to a butanoyl group (CCCC(=O)). It features a fused aromatic ring system with a tert-butyl substituent and an ether linkage connecting the two aromatic rings.",
            "Property Analysis": "The molecule exhibits structural complexity with both polar and non-polar functional groups, contributing to its intermediate QED score. The presence of the alkyne and tert-butyl groups affects its lipophilicity and molecular weight, which are critical factors in drug-likeness.",
            "Limitation in Source Molecule for Property": "The reactive alkyne group may pose synthetic challenges and potential reactivity issues. Additionally, the bulky tert-butyl substituent increases lipophilicity and molecular weight, potentially reducing solubility and overall drug-likeness.",
            "Optimization for Source Molecule": "To enhance QED, the alkyne moiety should be removed or replaced to decrease reactivity. The tert-butyl group can be substituted with a smaller alkyl group to reduce lipophilicity. Simplifying the aromatic system may also help lower the molecular weight and improve solubility.",
            "Final Target Molecule": "CCCCC(=O)c1cc2c(c(C)c1)OCC2"
        }
    },
    {
        "src_smiles": "CN(c1ccc(C=CC(=O)NO)cc1)S(=O)(=O)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a central nitrogen atom bonded to two aromatic rings. One aromatic ring is substituted with a vinyl ketone moiety (C=CC(=O)NO), and the other is connected via a sulfonyl group (S(=O)(=O)\u2212) to a phenyl ring. Functional groups present include sulfonamide, vinyl ketone, and a nitro group.",
            "Property Analysis": "The molecule has moderate drug-likeness (QED) influenced by multiple aromatic rings and hydrogen bond donors/acceptors, which are favorable. However, the presence of nitro groups and sulfonyl linkages may negatively impact solubility and increase toxicity risks, potentially lowering the overall QED score.",
            "Limitation in Source Molecule for Property": "The nitro group and sulfonyl functionalities contribute to higher lipophilicity and potential toxicity, which are detrimental to drug-likeness. Additionally, the molecular weight and number of hydrogen bond donors/acceptors may not optimally align with Lipinski's rules, limiting the QED.",
            "Optimization for Source Molecule": "Replace the nitro group with a less toxic and more metabolically stable amine group to reduce toxicity and improve solubility. Modify the sulfonyl linkage to a simpler amide to decrease molecular weight and enhance drug-likeness. Additionally, consider reducing the number of aromatic rings or introducing polar substituents to balance lipophilicity.",
            "Final Target Molecule": "CN(c1ccc(C=CC(=O)NH)cc1)S(=O)(=O)c1ccccc1"
        }
    },
    {
        "src_smiles": "O=C(NC(=S)NCc1ccco1)c1ccc([N+](=O)[O-])cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a benzamide core substituted with a nitro group, a thiourea linker, and a furan ring. The presence of multiple aromatic rings and polar functional groups contribute to its structural complexity.",
            "Property Analysis": "The molecule has a high quantitative estimate of drug-likeness (QED) due to its balanced distribution of hydrophobic and hydrophilic regions, appropriate molecular weight, and the presence of functional groups commonly found in drug molecules such as amides and heterocycles.",
            "Limitation in Source Molecule for Property": "The presence of the nitro group can be a liability due to its potential for metabolic reduction and toxicity. Additionally, the thiourea linkage may introduce liabilities related to metabolic stability and potential off-target interactions.",
            "Optimization for Source Molecule": "Replace the nitro group with a less toxic and more metabolically stable substituent such as a cyano or trifluoromethyl group. Modify the thiourea linker to a urea or carbamate to enhance metabolic stability and reduce potential off-target effects. Incorporate a single aromatic ring to reduce molecular complexity while maintaining essential interactions.",
            "Final Target Molecule": "O=C(NC(=O)NCc1ccco1)c1ccc(C#N)cc1"
        }
    },
    {
        "src_smiles": "CSc1nccc(C#Cc2ccc(CC(C)NC(C)=O)cc2)n1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The molecule consists of a thiocarbonyl group (C=S) attached to a pyridine ring. The pyridine is substituted with a propargyl group (C#C-) connected to a phenyl ring. This phenyl ring is further functionalized with a side chain containing an amino group linked to a ketone (NC(C)=O). The structure features multiple aromatic rings, a triple bond, and amide functionalities.",
            "Property Analysis": "The molecule has a moderate QED (Quantitative Estimate of Drug-likeness) score, balancing factors such as molecular weight, lipophilicity, and the presence of functional groups that are favorable for biological activity. However, certain structural elements may limit its overall drug-likeness.",
            "Limitation in Source Molecule for Property": "The thiocarbonyl group increases lipophilicity, potentially leading to poor solubility and bioavailability. The internal alkyne (triple bond) contributes to molecular rigidity and may negatively impact metabolic stability. Additionally, the extended aromatic system can result in higher molecular weight and reduced membrane permeability, detracting from QED.",
            "Optimization for Source Molecule": "To enhance QED, the thiocarbonyl group can be modified to a carbonyl (C=O) to improve solubility and reduce lipophilicity. Replacing the propargyl linker with a single bond could decrease molecular rigidity and weight. Introducing polar substituents or reducing the number of aromatic rings may further enhance drug-likeness by improving membrane permeability and metabolic stability.",
            "Final Target Molecule": "C=Oc1nccc(Cc2ccc(CC(C)NC(C)=O)cc2)n1)"
        }
    },
    {
        "src_smiles": "COc1ccc(C(=O)Nc2cccc(OC(=O)c3ccco3)c2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxy-substituted benzene ring connected via an amide linkage to another benzene ring, which is further bonded to an ester group attached to a 2-pyridone moiety. The structure features multiple aromatic rings, amide and ester functional groups, and a methoxy substituent, contributing to its overall rigidity and lipophilicity.",
            "Property Analysis": "The molecule exhibits moderate QED (quantitative estimate of drug-likeness) due to its balanced molecular weight, presence of hydrogen bond donors and acceptors, and adequate lipophilicity. However, the extensive aromatic systems and multiple ester functionalities may impact its solubility and metabolic stability negatively.",
            "Limitation in Source Molecule for Property": "The high number of aromatic rings and ester groups increase lipophilicity and molecular weight, which can reduce solubility and metabolic stability. Additionally, the multiple rotatable bonds and functional groups susceptible to metabolic cleavage may lower the overall QED score.",
            "Optimization for Source Molecule": "To enhance QED, reduce lipophilicity and molecular weight by replacing ester groups with more metabolically stable amide linkages. Simplify the aromatic systems to decrease rigidity and introduce polar functional groups to improve solubility. Specifically, substitute the ester-linked 2-pyridone with an amide linkage to enhance stability.",
            "Final Target Molecule": "COc1ccc(C(=O)Nc2cccc(NC(=O)c3ccco3)c2)cc1"
        }
    },
    {
        "src_smiles": "CN(CC(=O)Nc1ccc(S(N)(=O)=O)cc1)C(=N)N",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a dimethylamino group attached to an acetamide linker, which is connected to a benzene ring substituted with a sulfonamide group. Additionally, there is a guanidine moiety present in the structure, contributing to its overall complexity.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) for the source molecule indicates moderate drug-like properties. While it possesses key functional groups beneficial for biological activity, certain structural elements may hinder its optimal drug-likeness.",
            "Limitation in Source Molecule for Property": "The presence of the sulfonamide group and the guanidine moiety increases the molecule's polarity and molecular weight, potentially reducing its bioavailability and membrane permeability. These factors can negatively impact the QED score by making the compound less favorable as a drug candidate.",
            "Optimization for Source Molecule": "To enhance the QED property, the sulfonamide group can be replaced with a less polar substituent such as a methyl group to reduce polarity and molecular weight. Additionally, modifying the guanidine moiety to a less polar or more lipophilic group can improve membrane permeability and overall drug-likeness.",
            "Final Target Molecule": "CN(CC(=O)Nc1ccc(C)cc1)C(=N)N"
        }
    },
    {
        "src_smiles": "CCCCCCOc1ccc(C(=O)CCN2CCCCC2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a heptyl ether group attached to a substituted benzene ring. This benzene ring is further connected to an acetamide moiety, which is linked to a piperidine ring.",
            "Property Analysis": "The molecule has a moderate QED value, indicating reasonable drug-likeness. However, factors such as high lipophilicity and molecular weight may limit its pharmacokinetic properties.",
            "Limitation in Source Molecule for Property": "The extended alkyl chain and the bulky piperidine ring contribute to increased lipophilicity and molecular size, which can negatively affect solubility, bioavailability, and overall drug-likeness.",
            "Optimization for Source Molecule": "To enhance QED, reduce lipophilicity by shortening the alkyl chain from heptyl to butyl and replace the piperidine ring with a less bulky, more polar amine group such as morpholine.",
            "Final Target Molecule": "CCCCCOc1ccc(C(=O)CCN2OCC2)cc1"
        }
    },
    {
        "src_smiles": "CC(=O)NC(=Cc1ccc2c(c1)OCO2)C(=O)NCCCO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains an acetylamino group connected to a substituted bicyclic ether core, featuring a dihydrofuran ring fused to a benzene ring. Additionally, it has a propyl chain linked to another amide group, incorporating an alcohol functional group.",
            "Property Analysis": "The molecule exhibits moderate molecular weight, appropriate lipophilicity, and a balanced number of hydrogen bond donors and acceptors, contributing positively to its QED score. The fused ring system provides structural rigidity and potential for specific binding interactions.",
            "Limitation in Source Molecule for Property": "The presence of multiple amide groups may lead to metabolic instability and increased polarity, potentially reducing cell membrane permeability. The rigid fused ring system could limit molecular flexibility, affecting binding affinity and pharmacokinetic properties.",
            "Optimization for Source Molecule": "Introduce flexibility by modifying or replacing the rigid bicyclic ether core with a more flexible linker. Substitute one of the amide groups with a bioisostere to enhance metabolic stability. Add or modify polar functional groups to improve solubility without excessively increasing polarity.",
            "Final Target Molecule": "CC(=O)N(C)CC(O)C=CC1CCC(O)C1OCCN(CC)C(=O)OCCO"
        }
    },
    {
        "src_smiles": "CC(=O)NCC1CN(c2ccc(C(C)=NO)cc2)C(=O)O1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an acetamide group connected to a bicyclic hydantoin core. The hydantoin ring is substituted with a morpholine-like nitrogen atom linked to a phenyl ring bearing a C(C)=NO functional group.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness (QED) but may suffer from suboptimal solubility and permeability. The presence of multiple hydrogen bond donors and acceptors could affect its pharmacokinetic properties.",
            "Limitation in Source Molecule for Property": "High molecular weight and the C(C)=NO moiety may reduce lipophilicity and membrane permeability, negatively impacting the overall QED score.",
            "Optimization for Source Molecule": "Remove or modify the C(C)=NO group to enhance lipophilicity and reduce molecular weight. Introduce methyl or halogen substituents on the phenyl ring to improve binding affinity and maintain structural integrity.",
            "Final Target Molecule": "CC(=O)NCC1CN(c2ccc(CN)cc2)C(=O)O1"
        }
    },
    {
        "src_smiles": "CC(=NO)c1ccc(N2C(=O)C3CC=C(Cl)CC3C2=O)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a benzene ring substituted with an N-oxide group and a bicyclic core containing two carbonyl groups and a chlorine atom. The structure includes an ethylidene N-oxide moiety attached to the aromatic system.",
            "Property Analysis": "The molecule exhibits moderate molecular weight and lipophilicity due to the presence of the chlorine atom and multiple aromatic rings. The N-oxide and carbonyl groups contribute to its polarity. These characteristics result in a moderate QED value, indicating reasonable drug-likeness but with room for improvement.",
            "Limitation in Source Molecule for Property": "High lipophilicity from the chlorine atom and multiple aromatic rings may lead to poor solubility and bioavailability. The presence of the N-oxide and carbonyl groups increases polarity, potentially affecting membrane permeability. Additionally, the rigid bicyclic structure may limit conformational flexibility necessary for optimal target binding.",
            "Optimization for Source Molecule": "To enhance QED, reduce lipophilicity by removing or replacing the chlorine substituent with a less lipophilic group. Simplify the bicyclic core to increase molecular flexibility and improve solubility. Modify or eliminate polar functional groups to balance polarity and maintain necessary interactions for biological activity.",
            "Final Target Molecule": "CC(=NO)c1ccc(N2C(=O)C3CCCCCC3C2=O)cc1"
        }
    },
    {
        "src_smiles": "CCSCCSc1nnc(-c2ccc([N+](=O)[O-])cc2)s1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a disulfide-linked ethyl chains connected to a 1,2,4-triazole ring, which is further substituted with a nitrobenzene moiety. The presence of two disulfide bonds and the nitro group contribute to the molecule's rigidity and electron-withdrawing characteristics.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness with a QED score that is influenced by its molecular weight, lipophilicity, hydrogen bond donors and acceptors, and overall polar surface area. The nitro group and disulfide bonds impact its solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "The nitrobenzene group increases the molecule's lipophilicity and may lead to potential toxicity issues. Additionally, the disulfide bonds can be reactive under physiological conditions, potentially reducing metabolic stability and overall drug-likeness.",
            "Optimization for Source Molecule": "To enhance the QED score, the nitro group can be replaced with a less reactive electron-withdrawing group such as a cyano or trifluoromethyl group to reduce lipophilicity and toxicity. Furthermore, modifying the disulfide linkage to a more metabolically stable amide or ether bond can improve the molecule's stability and drug-likeness.",
            "Final Target Molecule": "CCSCCSc1nnc(-c2ccc(C(F)(F)F)cc2)s1"
        }
    },
    {
        "src_smiles": "O=C(O)C=Cc1cn(Cc2ccc([N+](=O)[O-])cc2)c2ccccc12",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an acrylic acid moiety (O=C(O)C=C) connected to a pyridine ring fused with a phenyl ring. Additionally, it contains a nitro-substituted aromatic ring, specifically a nitro group attached to the second phenyl ring.",
            "Property Analysis": "The molecule exhibits moderate molecular weight and high lipophilicity due to multiple aromatic rings. The presence of the nitro group contributes to electron-withdrawing characteristics, affecting hydrogen bonding and overall polarity. These properties influence its drug-likeness as assessed by QED.",
            "Limitation in Source Molecule for Property": "The nitro group significantly reduces the QED score by increasing potential toxicity and decreasing metabolic stability. High lipophilicity from multiple aromatic rings may also hinder solubility and bioavailability, negatively impacting drug-likeness.",
            "Optimization for Source Molecule": "To improve the QED property, replace the nitro group with a less problematic functional group such as an amino group to enhance metabolic stability and reduce toxicity. Additionally, consider reducing the number of aromatic rings to balance lipophilicity and solubility, thereby improving overall drug-like properties.",
            "Final Target Molecule": "O=C(O)C=Cc1cn(Cc2cccNcc2)c2ccccc12."
        }
    },
    {
        "src_smiles": "COc1ccc2c(CSCCBr)cc(=O)oc2c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a methoxy-substituted benzofuran with a brominated thioether side chain. It features a fused benzene and furan ring system, a methoxy group attached to the aromatic ring, and a thioether linkage with a bromine-substituted ethyl group.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness (QED) due to the presence of aromatic rings and heteroatoms which contribute to favorable interactions. However, the bromine atom increases molecular weight and lipophilicity, potentially reducing solubility and increasing toxicity. Additionally, the thioether linkage may be susceptible to metabolic degradation.",
            "Limitation in Source Molecule for Property": "The bromine substituent elevates lipophilicity and molecular weight, which can negatively impact solubility and drug-likeness. The thioether linkage may also reduce metabolic stability, limiting the molecule's overall QED.",
            "Optimization for Source Molecule": "To enhance QED, replace the bromine atom with a smaller, less lipophilic substituent such as a methyl group to reduce molecular weight and lipophilicity. Modify the thioether linkage to a more metabolically stable group like a sulfone. Additionally, retain the methoxy group to maintain favorable aromatic interactions.",
            "Final Target Molecule": "COc1ccc2c(CS(=O)C)cc(=O)oc2c1"
        }
    },
    {
        "src_smiles": "O=C(OCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)C1CCCN1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features an ester linkage connecting a substituted pyrimidine ring to a piperazine moiety. Key functional groups include a nitro-substituted phenyl ring and a triazole-like structure within the pyrimidine ring, contributing to its overall complexity and potential interactions.",
            "Property Analysis": "The molecule exhibits moderate QED, indicating reasonable drug-likeness. It possesses multiple polar functional groups, which enhance solubility but may adversely affect membrane permeability. The presence of a nitro group can also influence metabolic stability and toxicity profiles.",
            "Limitation in Source Molecule for Property": "The nitro group ([N+](=O)[O-]) is a significant limitation due to its association with potential toxicity and reduced metabolic stability, which negatively impacts the overall QED. Additionally, the molecular weight and lipophilicity of the molecule may be higher than optimal, further diminishing its drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, replace the nitro group with a less toxic and more metabolically stable functional group, such as a cyano group (\u2013C\u2261N). This modification can reduce toxicity and enhance metabolic stability. Additionally, consider altering the piperazine ring to a morpholine ring to optimize lipophilicity and reduce molecular weight.",
            "Final Target Molecule": "O=C(OCc1cn(-c2ccc(C#N)cc2)nn1)C1CCON1"
        }
    },
    {
        "src_smiles": "COc1ccc(CCNC(=O)CSc2nncn2N)cc1OC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a 1,4-dimethoxyphenyl core substituted with a side chain consisting of an ethylamine linked to an amide group. The amide is further connected to a thioether linkage leading to a pyrazole ring. Key structural elements include two methoxy groups on the aromatic ring, an amide bond, a thioether linkage, and a heterocyclic pyrazole moiety.",
            "Property Analysis": "The molecule exhibits moderate molecular weight and lipophilicity due to the presence of methoxy groups and the thioether linkage. It has multiple hydrogen bond donors and acceptors, contributing to its drug-likeness (QED). The aromatic rings and heterocyclic structures are favorable for pi-stacking interactions, enhancing potential binding with biological targets.",
            "Limitation in Source Molecule for Property": "The high lipophilicity from the methoxy groups and thioether linkage may lead to poor solubility and bioavailability. Additionally, the presence of multiple aromatic rings can increase the molecule's rigidity, potentially reducing its conformational adaptability necessary for optimal binding to diverse biological targets.",
            "Optimization for Source Molecule": "To enhance the QED, the methoxy groups can be replaced with more polar substituents such as hydroxyl or amino groups to reduce lipophilicity and improve solubility. The thioether linkage can be modified to a more polar ether or ester linkage to further decrease lipophilicity. Additionally, introducing small flexible linkers between the aromatic core and the side chain can increase conformational flexibility, potentially improving binding interactions.",
            "Final Target Molecule": "COc1cc(ccc1O)CCNCC(=O)OCC2nncn2N"
        }
    },
    {
        "src_smiles": "C#CCCCOc1ccc2c(C)cc(=O)oc2c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a pentynyl ether moiety connected to a benzofuran core. The benzofuran is fused with a six-membered ring containing a methyl group and a ketone functional group, resulting in a polycyclic aromatic structure.",
            "Property Analysis": "The molecule exhibits a moderate QED score, reflecting a balance between hydrophobicity and molecular complexity. However, certain structural features may limit its drug-likeness by affecting solubility and bioavailability.",
            "Limitation in Source Molecule for Property": "The presence of a triple bond in the pentynyl chain increases rigidity and lipophilicity, which can adversely impact solubility and permeability. Additionally, the molecular weight is relatively high, potentially exceeding optimal ranges for drug candidates.",
            "Optimization for Source Molecule": "To enhance the QED score, the alkyne bond in the pentynyl chain should be saturated to increase flexibility and reduce lipophilicity. Introducing polar functional groups or reducing molecular weight can further improve solubility and overall drug-likeness.",
            "Final Target Molecule": "CCCCCOc1ccc2c(C)cc(=O)oc2c1"
        }
    },
    {
        "src_smiles": "C#CCOCC(Cn1cncn1)c1ccc(Cl)cc1Cl",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features an ethynyl group connected to an ethylene glycol linker. It includes a 1,4-dichlorobenzene ring and a pyrimidine-like nitrogen-containing heterocycle. The presence of multiple aromatic chlorines and a flexible ether linkage contributes to its overall structure.",
            "Property Analysis": "The molecule demonstrates moderate drug-likeness with a QED score that indicates potential for optimization. It possesses reasonable molecular weight and lipophilicity but may suffer from poor aqueous solubility and excessive flexibility.",
            "Limitation in Source Molecule for Property": "Multiple chlorine atoms on the aromatic ring increase lipophilicity, potentially hindering solubility and bioavailability. The flexible ethylene glycol linker introduces several rotatable bonds, reducing the molecule's rigidity and negatively impacting the QED score.",
            "Optimization for Source Molecule": "Reduce the number of aromatic chlorine atoms to decrease lipophilicity and improve solubility. Replace the flexible ethylene glycol linker with a more rigid moiety to limit rotatable bonds, thereby enhancing rigidity and QED. Introduce polar functional groups to further improve aqueous solubility without compromising drug-likeness.",
            "Final Target Molecule": "C#CCNC(Cn1cncn1)c1ccc(Cl)cc1"
        }
    },
    {
        "src_smiles": "CCc1ccc(OC(C)=O)c(C(=O)c2ccc(C)cc2)c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a dimethyl group attached to a benzene ring, which is further substituted with an acetate ester (OC(C)=O) and a benzoyl group (C(=O)c2ccc(C)cc2).",
            "Property Analysis": "The molecule exhibits a moderate QED score, indicating reasonable drug-likeness based on factors such as molecular weight, lipophilicity, and the presence of multiple aromatic rings.",
            "Limitation in Source Molecule for Property": "High lipophilicity and the presence of multiple aromatic rings may lead to poor solubility and increased metabolic instability, adversely affecting the overall drug-likeness.",
            "Optimization for Source Molecule": "To enhance QED, replace the ester group with a more metabolically stable amide linkage, reduce lipophilicity by minimizing bulky substituents, and streamline the aromatic system to improve solubility and pharmacokinetic properties.",
            "Final Target Molecule": "CCc1ccc(NC(C)=O)c1"
        }
    },
    {
        "src_smiles": "Cn1c(=O)c2c(ncn2C)n(C)c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a substituted barbiturate featuring a pyrimidine core with two carbonyl (C=O) groups and three nitrogen atoms. Methyl groups are attached to two of the nitrogen atoms, providing alkyl substitution that can influence the molecule's lipophilicity and hydrogen bonding capabilities.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) of the source molecule is moderate. While the molecule possesses essential functional groups that contribute to drug-like properties, such as carbonyl groups and nitrogen atoms, its overall balance of hydrophilic and lipophilic characteristics may limit its drug-likeness score.",
            "Limitation in Source Molecule for Property": "The primary limitations affecting the QED of the source molecule include high polarity due to multiple carbonyl groups and nitrogen atoms, which may reduce membrane permeability. Additionally, the planar structure can lead to poor binding specificity, and the lack of structural diversity may hinder interaction with a broad range of biological targets.",
            "Optimization for Source Molecule": "To enhance the QED, structural modifications can be implemented to increase lipophilicity and conformational flexibility. Introducing alkyl chains to reduce polarity, adding aromatic rings to enhance binding interactions, and varying the substitution pattern on the nitrogen atoms can improve membrane permeability and target specificity. These changes aim to balance hydrophilic and lipophilic properties, thereby increasing overall drug-likeness.",
            "Final Target Molecule": "CCn1c(=O)c2c(ncn2CC)c(n(C)c1=O)C"
        }
    },
    {
        "src_smiles": "Nc1ccc(C=CC(=O)Nc2cccc(Cl)c2)cc1O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, Nc1ccc(C=CC(=O)Nc2cccc(Cl)c2)cc1O, consists of two aromatic rings connected via a propanamide linker. One aromatic ring is substituted with a hydroxyl group (-OH) and the other with a chlorine atom (Cl). The presence of both amine and hydroxyl functional groups suggests potential for hydrogen bonding, while the chlorine atom adds hydrophobic character.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness (QED) due to its balanced combination of hydrophilic and hydrophobic regions. The hydrogen bond donors and acceptors, along with the aromatic systems, contribute positively to its QED score. However, the presence of the chlorine atom may negatively impact solubility and increase lipophilicity.",
            "Limitation in Source Molecule for Property": "The chlorine substituent on the second aromatic ring increases the molecule's lipophilicity, potentially reducing its solubility and bioavailability. Additionally, halogen atoms can introduce toxicity concerns, which may adversely affect the overall QED score.",
            "Optimization for Source Molecule": "To enhance the QED property, the chlorine atom can be replaced with a less hydrophobic substituent such as a methyl group or a hydrogen atom. This modification aims to decrease lipophilicity, improve solubility, and reduce potential toxicity, thereby improving the drug-likeness of the molecule.",
            "Final Target Molecule": "Nc1ccc(C=CC(=O)Nc2cccc(c2))cc1O"
        }
    },
    {
        "src_smiles": "Cc1cn(C2CC(NC(=O)CC(=O)O)C(CO)O2)c(=O)[nH]c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a pyrimidine ring substituted with a methyl group at one position. It contains a complex side chain comprising a cyclohexane ring with hydroxyl functional groups and an amide linkage, which includes carbamate functionalities.",
            "Property Analysis": "The molecule has a moderate QED value, indicating partial drug-likeness. The presence of multiple hydroxyl groups enhances hydrogen bonding capacity, which is favorable for solubility and binding interactions. However, the extensive hydroxylation increases the molecule's polarity.",
            "Limitation in Source Molecule for Property": "High polarity due to multiple hydroxyl and amide groups may lead to poor cell membrane permeability, reducing bioavailability. Additionally, the molecular weight is relatively high, which can negatively impact oral absorption and overall drug-likeness.",
            "Optimization for Source Molecule": "To improve the QED value, reduce the number of hydroxyl groups to decrease polarity and enhance membrane permeability. Simplify the side chain by removing or modifying bulky functional groups, and consider introducing more lipophilic substituents to balance solubility and permeability without significantly compromising hydrogen bonding potential.",
            "Final Target Molecule": "Cc1cn(C2CC(NC(=O)CC(=O)O)C2)c(=O)[nH]c1=O"
        }
    },
    {
        "src_smiles": "CC(N)C(NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central carbon bonded to two amino groups and two carbonyl functionalities. It features an amide linkage to a substituted aromatic ring that includes a phenylacetylene moiety, and a nitroso group attached to another carbonyl. The molecule contains multiple aromatic rings, an alkyne group, and several hydrogen bond donors and acceptors.",
            "Property Analysis": "The molecule has high lipophilicity due to multiple aromatic and alkyne groups, which may lead to poor solubility and bioavailability. It also possesses several hydrogen bond donors and acceptors, contributing to a high number of potential hydrogen bonds. The presence of reactive groups like the nitroso moiety may affect stability and safety profiles, potentially reducing drug-likeness as assessed by QED.",
            "Limitation in Source Molecule for Property": "Excessive lipophilicity and multiple hydrogen bond donors/acceptors can hinder drug-likeness by reducing solubility and permeability. The alkyne and nitroso groups introduce reactivity that may lead to metabolic instability and toxicity, further compromising the molecule's suitability as a drug candidate.",
            "Optimization for Source Molecule": "To enhance QED, reduce lipophilicity by simplifying the aromatic system and removing the alkyne group. Eliminate the reactive nitroso moiety to improve stability and safety. Decrease the number of hydrogen bond donors and acceptors by modifying or removing certain functional groups, thereby improving solubility and bioavailability.",
            "Final Target Molecule": "CC(N)C(NC(=O)c1ccc(C)c2ccccc2)C(=O)O"
        }
    },
    {
        "src_smiles": "CN=C(NC#N)NCCn1nc(-c2ccccc2)ccc1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule CN=C(NC#N)NCCn1nc(-c2ccccc2)ccc1=O contains multiple functional groups including an amidine moiety (CN=C(NC#N)N), a nitrile group (NC#N), an ethylene linker (NCC), and a pyridine ring substituted with a phenyl group and a carbonyl group. The molecule exhibits a conjugated system with both aromatic and aliphatic segments.",
            "Property Analysis": "The current QED (Quantitative Estimate of Drug-likeness) of the molecule may be moderately favorable due to the presence of aromatic rings and functional groups that interact well with biological targets. However, the overall drug-likeness could be affected by factors such as molecular weight, the presence of multiple nitrogen atoms, and the nitrile group.",
            "Limitation in Source Molecule for Property": "The nitrile group (NC#N) can reduce the drug-likeness by increasing molecular rigidity and polarity, potentially leading to poor membrane permeability. Additionally, the presence of multiple nitrogen atoms may contribute to high basicity, which can affect the molecule's pharmacokinetic properties.",
            "Optimization for Source Molecule": "To improve the QED, the nitrile group can be replaced with a less polar bioisostere, such as a trifluoromethyl group, to enhance lipophilicity and membrane permeability. Reducing the number of nitrogen atoms by modifying the amidine moiety to a secondary amine can also decrease basicity and improve drug-likeness. Maintaining the aromatic systems while ensuring balanced molecular weight will contribute positively to the overall QED.",
            "Final Target Molecule": "CN=C(NC(F)F)NCCn1nc(-c2ccccc2)ccc1=O"
        }
    },
    {
        "src_smiles": "CC(N)C(NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a central amino acid backbone with multiple functional groups, including primary amines, amides, a nitro group, and an extended aromatic system featuring a carbon-carbon triple bond. The presence of chiral centers and extensive aromaticity contributes to the molecule's complexity and potential biological interactions.",
            "Property Analysis": "The molecule exhibits several drug-like properties such as appropriate molecular weight, presence of hydrogen bond donors and acceptors, and aromatic structures that can facilitate binding. However, the nitro group and multiple amine functionalities may negatively impact solubility, membrane permeability, and metabolic stability.",
            "Limitation in Source Molecule for Property": "The nitro group is associated with increased toxicity and metabolic instability, while the multiple amine groups can lead to high polarity, reducing membrane permeability and oral bioavailability. Additionally, the extensive aromatic system may result in poor selectivity and potential off-target effects.",
            "Optimization for Source Molecule": "Removed the nitro group to enhance metabolic stability and reduce toxicity. Modified the aromatic system by simplifying the structure, thus improving bioavailability and reducing molecular complexity. Reduced the number of amine groups to lower polarity, enhancing membrane permeability and overall drug-likeness.",
            "Final Target Molecule": "CC(N)C(NC(=O)c1ccccc1C#Cc2ccccc2)C(=O)O"
        }
    },
    {
        "src_smiles": "COc1nc(OCC(=N)NO)nc(N2CCOCC2)n1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a 1,2,4-triazole ring substituted with a methoxy group at the 1-position. It features a side chain containing an ethoxy group linked to a hydroxylamine moiety (OCC(=N)NO) and incorporates a piperazine ring attached to the triazole nitrogen.",
            "Property Analysis": "The molecule exhibits moderate QED (Quantitative Estimate of Drug-likeness) with balanced hydrogen bond donors and acceptors. However, it has a relatively high molecular weight and multiple rotatable bonds, which may negatively impact its drug-like properties by reducing bioavailability and increasing metabolic instability.",
            "Limitation in Source Molecule for Property": "The high number of rotatable bonds and the presence of both ethyl and piperazine linkers contribute to increased molecular flexibility and molecular weight, detracting from optimal QED scores. Additionally, the hydroxylamine moiety may pose stability and toxicity concerns.",
            "Optimization for Source Molecule": "To enhance QED, reduce molecular weight and flexibility by simplifying the side chains. Replace the ethoxy linker with a less flexible linker and consider modifying or removing the hydroxylamine group to improve stability and reduce potential toxicity. Introducing rigid structural elements can lower the number of rotatable bonds, enhancing drug-likeness.",
            "Final Target Molecule": "COc1nc(N2CCOCC2)ncc1=O"
        }
    },
    {
        "src_smiles": "Cc1nc(C#Cc2cnc(SC(C)(C)C)nc2)cs1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a thiazole ring fused with a pyrazole ring. It contains a methyl group attached to the thiazole nitrogen, a propargyl linker connecting to a substituted pyrazole, and a sulfur-linked tert-butyl group on the pyrazole ring.",
            "Property Analysis": "The molecule has moderate molecular weight and lipophilicity, with multiple nitrogen and sulfur atoms contributing to its drug-likeness (QED). The presence of aromatic rings and heteroatoms may enhance binding interactions with biological targets.",
            "Limitation in Source Molecule for Property": "The bulky tert-butyl groups increase molecular size and lipophilicity, potentially reducing solubility and bioavailability. Additionally, the propargyl moiety may be prone to metabolic instability, affecting the molecule's overall drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, replace bulky tert-butyl groups with smaller alkyl substituents to reduce molecular size and lipophilicity. Modify the propargyl linker to a more metabolically stable moiety, such as an amide or ether linkage. Introduce polar functional groups to enhance solubility without significantly increasing molecular weight.",
            "Final Target Molecule": "Cc1nc(CC=O)c2ncc(SC(C)C)nc2cs1"
        }
    },
    {
        "src_smiles": "C[N+]([O-])=Cc1ccc2c(c1)OCO2",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a nitro-functionalized ethene moiety (C[N+]([O-])=C) connected to a bicyclic ether structure, specifically a benzofuran derivative with an additional ether bridge (c1ccc2c(c1)OCO2).",
            "Property Analysis": "The molecule exhibits moderate QED value due to the presence of both polar functional groups and ring systems. It contains a positively charged nitrogen with a counterion, which may affect solubility and permeability. The aromatic rings contribute to a planar structure, favorable for stacking interactions in drug targets.",
            "Limitation in Source Molecule for Property": "The presence of a charged nitrogen and nitro group increases polarity, which can negatively impact membrane permeability and reduce drug-likeness. Additionally, the rigid bicyclic ether structure may limit conformational flexibility necessary for optimal binding to diverse biological targets.",
            "Optimization for Source Molecule": "To improve QED, the charged nitrogen can be modified to a neutral amine to reduce polarity. The nitro group can be replaced with a less polar functional group such as an amino or methoxy group. Additionally, introducing flexible linkers or reducing the size of the polycyclic system can enhance conformational flexibility, thereby improving membrane permeability and overall drug-likeness.",
            "Final Target Molecule": "CN=Cc1ccc2c(c1)OCO2"
        }
    },
    {
        "src_smiles": "NC(=NO)c1ccc(C=Cc2ccc(O)cc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The molecule NC(=NO)c1ccc(C=Cc2ccc(O)cc2)cc1 consists of a benzene ring substituted with a vinyl linkage connecting to another phenyl ring bearing a hydroxyl group (phenol). Additionally, it contains an oxime-like functional group (NC(=NO)) attached to the benzene ring.",
            "Property Analysis": "The source molecule exhibits features common in drug-like compounds, including aromatic rings and hydroxyl groups which contribute to hydrogen bonding and solubility. The conjugated double bonds may enhance electronic properties and membrane permeability. The Quantitative Estimate of Drug-likeness (QED) assesses factors such as molecular weight, lipophilicity (logP), and the balance of polar and non-polar regions.",
            "Limitation in Source Molecule for Property": "The presence of the oxime functional group (NC(=NO)) may introduce excessive polarity, potentially decreasing membrane permeability and metabolic stability, which can negatively impact the QED score. Additionally, the extended conjugation might result in high lipophilicity, adversely affecting solubility and bioavailability.",
            "Optimization for Source Molecule": "To enhance the QED, replace the oxime group with a less polar and more stable functional group such as an amide (NC(=O)R). This modification can reduce excessive polarity and improve metabolic stability. Additionally, consider limiting the extent of conjugation by modifying the vinyl linkage to achieve a better balance between lipophilicity and solubility.",
            "Final Target Molecule": "NC(=O)c1ccc(C=Cc2ccc(O)cc2)cc1"
        }
    },
    {
        "src_smiles": "Nc1ccccc1-c1cc(=O)c2ccc3ccccc3c2o1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises an aniline group bonded to a benzamide moiety, which is further connected to a polyaromatic oxygen-containing ring system featuring a carbonyl group.",
            "Property Analysis": "The molecule exhibits a moderate QED score, indicating reasonable drug-likeness. Its structure includes multiple aromatic rings and functional groups that contribute to its pharmacokinetic properties but may also affect solubility and bioavailability.",
            "Limitation in Source Molecule for Property": "The high number of aromatic rings and increased molecular weight may negatively impact solubility and permeability, thereby reducing the overall QED by decreasing drug-likeness metrics such as lipophilicity and molecular complexity.",
            "Optimization for Source Molecule": "To enhance QED, the molecule can be optimized by reducing the number of aromatic rings to lower molecular weight and lipophilicity, introducing polar substituents to improve solubility, and modifying the amine group to decrease basicity, thereby improving drug-likeness parameters.",
            "Final Target Molecule": "Nc1ccccc1-c1cc(=O)c2ccco2"
        }
    },
    {
        "src_smiles": "NS(=O)(=O)c1ccc(NC(=S)NC(=O)c2cccc([N+](=O)[O-])c2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a sulfonamide group attached to a benzene ring. It includes a thiocarbamate moiety linked to another aromatic ring bearing a nitro group in the form of a nitro anion. The molecule contains multiple functional groups, including sulfonamide, thiocarbamate, amide, and nitro functionalities, contributing to its overall complexity and potential reactivity.",
            "Property Analysis": "The current QED (Quantitative Estimation of Drug-likeness) score is moderate. The molecule has a relatively high molecular weight and contains multiple hydrogen bond donors and acceptors, which may affect its solubility and permeability. Additionally, the presence of charged groups can influence its lipophilicity and bioavailability.",
            "Limitation in Source Molecule for Property": "The molecule's high molecular weight and excessive hydrogen bonding potential may hinder its ability to permeate cell membranes effectively. The charged nitro group decreases lipophilicity, potentially reducing oral bioavailability. These factors collectively lower the QED score, indicating suboptimal drug-like properties.",
            "Optimization for Source Molecule": "To enhance the QED property, structural modifications can be made to reduce molecular weight and hydrogen bonding capacity. Removing or replacing the charged nitro group with a more lipophilic substituent can improve membrane permeability. Simplifying the molecule by eliminating unnecessary functional groups or altering linkage points can also contribute to a better drug-like profile.",
            "Final Target Molecule": "NS(=O)C1=CC=CC(NC=O)C=C1"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccccc1)N1CCN(Cc2ccc(C=Cc3ccccc3)cc2)CC1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a urea functional group connected to a piperazine ring. The piperazine is substituted with a benzyl group and a biphenyl moiety, introducing multiple aromatic rings and potential sites for hydrogen bonding. The molecular structure is relatively rigid due to the presence of fused aromatic systems.",
            "Property Analysis": "The molecule exhibits moderate to high lipophilicity due to multiple aromatic rings, which may enhance membrane permeability. It has several hydrogen bond donors and acceptors, contributing to good solubility and potential binding interactions with biological targets. However, the rigidity and size of the molecule might affect its oral bioavailability and metabolic stability.",
            "Limitation in Source Molecule for Property": "High lipophilicity and multiple aromatic systems may lead to poor aqueous solubility and increased risk of non-specific binding, potentially reducing the drug-likeness (QED) of the molecule. Additionally, the molecular weight and rigidity might hinder optimal pharmacokinetic properties.",
            "Optimization for Source Molecule": "To improve QED, reduce lipophilicity by modifying or removing one of the aromatic rings. Introduce polar functional groups to enhance solubility and maintain necessary hydrogen bonding capabilities. Simplify the molecular structure to increase flexibility, which can improve oral bioavailability and metabolic stability.",
            "Final Target Molecule": "O=C(Nc1ccccc1)N1CCN(CC1)Cc2ccccc2"
        }
    },
    {
        "src_smiles": "O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1cccc([N+](=O)[O-])c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central amide linkage connecting a triazole-substituted aniline to a nitro-substituted benzoyl group. It features multiple aromatic rings, including benzene and triazole moieties, as well as electron-withdrawing nitro and carbonyl functional groups.",
            "Property Analysis": "The molecule exhibits high aromaticity and electron-withdrawing characteristics, contributing to its potential interactions with biological targets. However, these features also result in increased lipophilicity and molecular complexity, which can negatively impact solubility and overall drug-likeness as measured by QED.",
            "Limitation in Source Molecule for Property": "The excessive number of aromatic rings and the presence of nitro groups elevate lipophilicity and molecular weight, which may reduce solubility and increase toxicity. Additionally, the molecule's high complexity can hinder pharmacokinetic properties and synthetic accessibility, thereby lowering its QED score.",
            "Optimization for Source Molecule": "To enhance the QED, the molecule can be simplified by reducing the number of aromatic rings, replacing the nitro group with a less toxic and more polar substituent such as an amine or hydroxyl group, and introducing polar linkers to improve solubility. These modifications aim to balance lipophilicity and polarity, thereby improving overall drug-likeness.",
            "Final Target Molecule": "O=C(NC(Cc1ccccc1)C1=NC=CC=C1)c1ccc(cc1)N"
        }
    },
    {
        "src_smiles": "Cc1c(Cc2cccc([N+](=O)[O-])c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a fused aromatic ring system with two ester linkages and a nitro substituent. It contains a dimethyl amide group and multiple methyl groups, contributing to its overall hydrophobic character.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness (QED), influenced by its aromaticity, molecular weight, and the presence of functional groups such as nitro and ester. While the aromatic rings enhance binding potential, the nitro group negatively impacts solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "The nitro group is a major liability, as it can reduce bioavailability and increase toxicity. Additionally, multiple ester linkages may lead to rapid hydrolysis in biological systems, further diminishing drug-like properties.",
            "Optimization for Source Molecule": "Replace the nitro group with a less problematic functional group, such as a cyano or amine group, to improve solubility and reduce toxicity. Modify ester linkages to more stable amide groups to enhance metabolic stability. Reduce the number of methyl substitutions to balance hydrophobicity.",
            "Final Target Molecule": "Cc1c(Cc2cccc(C#N)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12"
        }
    },
    {
        "src_smiles": "O=C(COC(=O)c1ccccc1)Nc1ccc(Cl)cc1C(=O)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a central ester linkage connecting two benzoyl groups and a 4-chlorophenyl moiety. It features multiple aromatic rings, ester and amide functional groups, and a chlorine substituent on the phenyl ring, contributing to its overall rigidity and lipophilicity.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) of the molecule is influenced by its molecular weight, lipophilicity, number of hydrogen bond donors and acceptors, and the presence of halogen atoms. High molecular weight and excessive lipophilicity can negatively impact drug-likeness by affecting solubility and bioavailability.",
            "Limitation in Source Molecule for Property": "The molecule has a high molecular weight and multiple aromatic rings, which increase lipophilicity and may reduce solubility. The presence of a chlorine atom adds to lipophilic character and can hinder metabolic stability. Additionally, the multiple ester and amide linkages may be susceptible to hydrolysis, affecting the molecule's stability.",
            "Optimization for Source Molecule": "To enhance QED, reduce molecular weight by removing one benzoyl group, replace the chlorine atom with a less lipophilic substituent such as a methyl group, and modify ester linkages to more metabolically stable amide bonds. Introducing polar functional groups could improve solubility and overall drug-likeness.",
            "Final Target Molecule": "O=C(Nc1ccccc1)C(=O)c1ccccc1"
        }
    },
    {
        "src_smiles": "Cn1cnc2cc(-c3ccc(C(=N)NO)cc3)nc(N3CCC(CO)C3)c2c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a quinazoline derivative featuring a fused bicyclic structure with a substituted phenyl ring containing a nitroso group and a piperazine ring linked to a hydroxyl group.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness (QED) but may face challenges related to solubility and molecular flexibility.",
            "Limitation in Source Molecule for Property": "The presence of the nitroso group and the piperazine ring increases molecular weight and polarity, potentially reducing bioavailability and QED.",
            "Optimization for Source Molecule": "Modify the nitroso group to a less polar functional group, reduce molecular weight by simplifying substituents, and alter the piperazine ring to enhance drug-likeness.",
            "Final Target Molecule": "Cn1cnc2cc(-c3ccc(C=O)cc3)nc(N3CCC(CO)C3)c2c1=O"
        }
    },
    {
        "src_smiles": "COCCSc1nnc(NC(=O)CCS(=O)(=O)Cc2ccccc2)s1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a five-membered heterocyclic ring containing sulfur and two nitrogen atoms. It is substituted with a methoxyethylthio group and an amide linkage connected to a sulfonylethylphenyl moiety. The presence of multiple heteroatoms and aromatic rings contributes to its structural complexity.",
            "Property Analysis": "The molecule exhibits moderate QED (Quantitative Estimate of Drug-likeness) due to its balanced combination of hydrophobic and hydrophilic groups, aromatic rings, and appropriate molecular weight. However, certain structural elements may limit its drug-like properties.",
            "Limitation in Source Molecule for Property": "The presence of multiple sulfur-containing groups (thioether and sulfonyl) and the extended aromatic system may decrease solubility and increase molecular weight, potentially negatively impacting drug-likeness. Additionally, the molecule may possess higher lipophilicity, which can affect bioavailability.",
            "Optimization for Source Molecule": "To improve QED, reduce molecular weight and lipophilicity by modifying or removing excessive sulfur-containing groups. Introduce polar functional groups to enhance solubility without significantly increasing molecular complexity. Simplify the aromatic system to maintain essential interactions while improving drug-like properties.",
            "Final Target Molecule": "COCCSc1nnc(NC(=O)CCl)s1"
        }
    },
    {
        "src_smiles": "O=C(CSc1ncccn1)Nc1ccc(S(=O)(=O)N2CCCCC2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an amide linkage connecting a thioether group to a pyridine-containing benzene ring, which is further substituted with a sulfonamide linked to a piperidine ring.",
            "Property Analysis": "The molecule displays moderate drug-likeness with a QED score influenced by its aromatic rings, basic nitrogen atoms, and overall molecular complexity.",
            "Limitation in Source Molecule for Property": "High lipophilicity and molecular weight due to multiple aromatic rings and sulfur-containing groups may reduce solubility and bioavailability, negatively affecting the QED score.",
            "Optimization for Source Molecule": "To enhance QED, reduce lipophilicity by replacing the thioether with an ether group, thereby decreasing molecular weight and improving solubility. Simplifying the aromatic system and introducing polar functionalities can further improve drug-likeness.",
            "Final Target Molecule": "O=C(CCOc1ncccn1)Nc1ccc(S(=O)(=O)N2CCCCC2)cc1"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1)c1cccc([N+](=O)[O-])c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an amide linkage connecting two aromatic rings. One aromatic ring is substituted with a sulfonamide group attached to a pyridine ring, while the other aromatic ring bears a nitro group. The presence of multiple aromatic systems, sulfonamide, and nitro functionalities contribute to the molecule's overall structure.",
            "Property Analysis": "The molecule exhibits properties such as high aromaticity, presence of strong electron-withdrawing groups (sulfonamide and nitro), and potential for hydrogen bonding due to the amide and sulfonamide functionalities. These features may contribute to good binding affinity but could negatively impact solubility and permeability.",
            "Limitation in Source Molecule for Property": "The high degree of aromaticity and the presence of the nitro group can adversely affect the drug-likeness (QED) by increasing molecular rigidity, reducing solubility, and potentially introducing toxicity. Additionally, the molecule may have a high molecular weight and poor membrane permeability.",
            "Optimization for Source Molecule": "To improve the QED, the nitro group can be replaced with a less electron-withdrawing and more biocompatible substituent such as an amino group. Introducing aliphatic linkers can reduce aromaticity and increase molecular flexibility. Additionally, modifying the sulfonamide group to a more favorable bioisostere can enhance solubility and reduce potential toxicity.",
            "Final Target Molecule": "O=C(Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1)c1ccccc1"
        }
    },
    {
        "src_smiles": "CCC(=O)Oc1ccc(NC(=O)c2ccc(S(=O)(=O)N3CCCC3)cc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a propyl ester group connected to a benzene ring substituted with an amide linkage. This amide is attached to another benzene ring which is further functionalized with a sulfonamide group linked to a piperazine ring. The structure contains multiple aromatic rings and several polar functional groups, contributing to its overall complexity.",
            "Property Analysis": "The molecule exhibits a moderate QED (Quantitative Estimate of Drug-likeness) score. While it contains aromatic rings that can enhance binding interactions, the presence of multiple polar functional groups and a relatively high molecular weight may adversely affect its drug-like properties such as solubility and membrane permeability.",
            "Limitation in Source Molecule for Property": "The complexity arising from multiple aromatic rings, high molecular weight, numerous polar functional groups (amide, sulfonamide), and several rotatable bonds likely contribute to suboptimal QED. These factors can lead to increased molecular rigidity and reduced bioavailability.",
            "Optimization for Source Molecule": "To enhance QED, the molecule can be simplified by reducing molecular weight and the number of rotatable bonds. Removing the sulfonamide group decreases polarity and can improve membrane permeability. Additionally, streamlining the ester linkage may further optimize drug-likeness.",
            "Final Target Molecule": "CCC(=O)Oc1ccc(NC(=O)c2cccN3CCCC3)cc1"
        }
    },
    {
        "src_smiles": "O=C(CCCC1CCN(S(=O)(=O)c2ccc3c(c2)CCO3)CC1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an amide linkage connected to a four-carbon chain, which is attached to a piperidine ring. The piperidine ring is substituted with a sulfonyl group linked to a fused aromatic system containing oxygen atoms.",
            "Property Analysis": "The molecule has moderate drug-likeness with a Quantitative Estimate of Drug-likeness (QED) score influenced by its molecular weight, lipophilicity, hydrogen bond donors and acceptors, and the presence of multiple rotatable bonds.",
            "Limitation in Source Molecule for Property": "The high molecular weight, multiple rotatable bonds, and the presence of a sulfonyl group may negatively impact the QED by reducing solubility and permeability, thus affecting the drug-likeness of the molecule.",
            "Optimization for Source Molecule": "Simplify the molecular structure by reducing ring complexity, decreasing the number of rotatable bonds, and modifying or removing the sulfonyl group to enhance solubility and permeability. This may involve replacing the sulfonyl group with a less polar substituent and shortening the alkyl chain to lower molecular weight.",
            "Final Target Molecule": "O=C(CCCC1CCN(CC1)NO)C"
        }
    },
    {
        "src_smiles": "O=C(CCCCCCc1ccccc1)c1ncc(-c2cc([N+](=O)[O-])ccn2)o1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a benzoyl group connected to a hexyl chain, which is further attached to a bicyclic nitrogen-containing heterocycle. Specifically, it features an amide linkage, a long aliphatic chain, a substituted aromatic ring, and a nitro functional group within the heterocycle.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness (QED) due to its balanced molecular weight and the presence of both aromatic and polar functional groups. However, the extended aliphatic chain and nitro group may adversely affect solubility and metabolic stability, impacting its overall pharmacokinetic profile.",
            "Limitation in Source Molecule for Property": "The long hexyl chain increases lipophilicity, which can lead to poor solubility and membrane permeability issues. Additionally, the nitro group is associated with potential toxicity and metabolic instability, which detracts from the molecule's drug-likeness and safety profile.",
            "Optimization for Source Molecule": "To enhance QED, the aliphatic hexyl chain can be shortened or replaced with a more polar substituent to improve solubility. The nitro group should be modified to a less toxic and more metabolically stable functional group, such as an amino or hydroxyl group. Introducing heteroatoms or polar functionalities can further enhance solubility and reduce lipophilicity.",
            "Final Target Molecule": "O=C(CCc1ccccc1)c1ncc(-c2cc(N)ccn2)o1"
        }
    },
    {
        "src_smiles": "CCN1c2ncc(COc3cc[n+]([O-])cc3)cc2C(=O)N(C)c2cccnc21",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a piperazine ring fused with a pyridine moiety. It is substituted with a methoxyphenyl group and contains an N-oxide functional group. The structure includes multiple nitrogen and oxygen heteroatoms, contributing to its overall complexity.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) of the source molecule is moderate. While it has a balanced molecular weight and appropriate lipophilicity, the presence of multiple heteroatoms and the N-oxide group may negatively impact its drug-likeness by increasing polarity and reducing membrane permeability.",
            "Limitation in Source Molecule for Property": "The N-oxide group increases the molecule's polarity, which can hinder cell membrane permeability and reduce bioavailability. Additionally, the multiple heterocyclic rings contribute to molecular complexity, potentially affecting synthesis and metabolic stability.",
            "Optimization for Source Molecule": "To enhance the QED, the N-oxide group should be removed to decrease polarity. Simplifying the heterocyclic structure by reducing the number of nitrogen and oxygen atoms will improve drug-likeness. Replacing the methoxyphenyl group with a less polar substituent can further enhance membrane permeability and overall drug-like properties.",
            "Final Target Molecule": "CCN1c2ncc(c3ccncc3)cc2C(=O)N(C)c2cccnc21"
        }
    },
    {
        "src_smiles": "COc1ccc(C(=O)Nc2ccccc2-c2nc3ncccc3[nH]2)cc1OC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxy-substituted benzamide linked to a fused aromatic system containing a triazole ring. It features multiple aromatic rings, including methoxy groups which contribute to electron density and overall aromaticity.",
            "Property Analysis": "The molecule exhibits characteristics typical of drug-like compounds, such as a moderate molecular weight and the presence of hydrogen bond donors and acceptors. However, the extensive aromatic system and multiple methoxy groups may lead to high lipophilicity, potentially affecting solubility and bioavailability.",
            "Limitation in Source Molecule for Property": "High degree of aromaticity and multiple methoxy substituents can negatively impact solubility and reduce the overall drug-likeness (QED) by increasing lipophilicity and reducing molecular flexibility.",
            "Optimization for Source Molecule": "To enhance QED, reduce the number of aromatic rings to decrease lipophilicity, replace some methoxy groups with more polar or hydrogen bond-friendly substituents to improve solubility, and introduce structural flexibility to balance the molecule's properties.",
            "Final Target Molecule": "COc1cc(CC(=O)Nc2ccccc2-c2nc3ncccc3[nH]2)cc(OC)c1O"
        }
    },
    {
        "src_smiles": "CN(C)CCCn1c(N)c(-c2nc3ccccc3s2)c2nc(C#N)c(C#N)nc21",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a tertiary amine (CN(C)) linked to a flexible alkyl chain and a complex heterocyclic system. It features a piperazine-like core with multiple nitrogen atoms, two nitrile (C#N) groups, a thiazole ring, and aromatic benzene rings.",
            "Property Analysis": "The molecule exhibits several features favorable for drug-likeness, including a balanced number of hydrogen bond donors and acceptors, aromatic rings contributing to planarity, and a tertiary amine which can aid in bioavailability. However, the presence of multiple heteroatoms and nitrile groups may affect solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "Excessive polarity due to multiple nitrile groups and nitrogen atoms may reduce cell membrane permeability. The rigid heterocyclic structures might limit conformational flexibility, potentially impacting binding affinity. Additionally, the molecular weight is on the higher side, which could affect oral bioavailability.",
            "Optimization for Source Molecule": "To improve the QED property, reduce the number of nitrile groups to decrease polarity, introduce a more flexible linker to enhance conformational adaptability, and consider replacing one of the aromatic rings with a less polar heterocycle to balance hydrophobic and hydrophilic properties.",
            "Final Target Molecule": "CN(C)CCCn1c(N)c(-c2nc3ccccc3s2)c2nc(C#N)nc21"
        }
    },
    {
        "src_smiles": "O=C(NCC1CCCO1)C(=Cc1cccc([N+](=O)[O-])c1)NC(=O)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central diketopiperazine core with multiple functional groups. It includes two amide linkages connecting to aromatic benzene rings, a nitro-substituted benzene ring, and a piperidine ring. The presence of both aliphatic and aromatic components, as well as polar functional groups like nitro and amide groups, contribute to the molecule's complexity.",
            "Property Analysis": "The molecule exhibits moderate molecular weight, multiple hydrogen bond donors and acceptors, and a certain degree of lipophilicity due to aromatic rings. These factors contribute to its QED score, indicating drug-likeness properties. However, the presence of potentially reactive nitro groups and the balance between hydrophilicity and lipophilicity are critical.",
            "Limitation in Source Molecule for Property": "The nitro group present on the aromatic ring can decrease the QED by increasing molecular complexity and potential toxicity. Additionally, the molecule may have excessive hydrogen bond donors or acceptors, making it less drug-like. The balance between hydrophilic and lipophilic regions may not be optimal for drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, modify the nitro group to a less polar substituent, such as a cyano or methyl group. Reduce the number of hydrogen bond donors by modifying or removing amide groups. Enhance lipophilicity without compromising solubility by optimizing the aromatic rings. Simplify the molecular structure to reduce complexity while maintaining essential interactions.",
            "Final Target Molecule": "O=C(NCC1CCCO1)C(=Cc1ccc(cc1)C#N)NC(=O)c1ccccc1"
        }
    },
    {
        "src_smiles": "O=C(C=Cc1ccc(CCNC(=O)c2ccc3c(c2)OCO3)cc1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a conjugated system with a carbonyl group, multiple aromatic rings, a secondary amine linked to an amide, and a cyclic ether moiety. It features a nitroso group attached to the carbonyl, contributing to its overall structure.",
            "Property Analysis": "The molecule has a high lipophilicity (logP), multiple hydrogen bond donors and acceptors, and a substantial molecular weight. These properties contribute to its drug-likeness as measured by the QED metric but may also pose challenges for bioavailability and solubility.",
            "Limitation in Source Molecule for Property": "The high lipophilicity and molecular weight, along with multiple hydrogen bond donors, may negatively impact the drug-likeness by affecting solubility and permeability. Additionally, the presence of multiple aromatic rings can contribute to poor pharmacokinetic properties.",
            "Optimization for Source Molecule": "To improve QED, reduce lipophilicity by introducing polar functional groups or reducing aromatic ring systems. Simplify the molecular structure by removing or modifying the cyclic ether moiety and limiting the number of hydrogen bond donors. This can enhance solubility and permeability while maintaining necessary biological activity.",
            "Final Target Molecule": "O=C(C=Cc1ccc(CCNCO)cc1)NO"
        }
    },
    {
        "src_smiles": "CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)C(C)(C)C(=O)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central carbonyl-linked structure with multiple amide bonds. It contains a methylated amine (CNC(=O)), a benzyl group (Cc1ccccc1), and several bulky tert-butyl groups (C(C)(C)C(=O)NO) attached to the central framework. The molecule exhibits a relatively rigid structure with multiple carbonyl functionalities and aromatic rings.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) for the source molecule is moderate. While it contains aromatic rings and amide bonds which are favorable for drug-likeness, the molecule is relatively large and contains multiple bulky groups that may hinder its drug-like properties, such as solubility and permeability.",
            "Limitation in Source Molecule for Property": "The primary limitations affecting the QED of the source molecule include its high molecular weight, excessive bulkiness due to multiple tert-butyl groups, and a high number of hydrogen bond donors and acceptors. These factors can negatively impact the molecule's solubility and permeability, reducing its overall drug-likeness.",
            "Optimization for Source Molecule": "To improve the QED, the molecule can be optimized by reducing its molecular weight and bulkiness. This can be achieved by removing or replacing the bulky tert-butyl groups with smaller alkyl groups, thereby increasing flexibility and improving solubility. Additionally, minimizing the number of hydrogen bond donors and acceptors by modifying amide groups can enhance permeability.",
            "Final Target Molecule": "CNC(=O)C(Cc1ccccc1)NC(=O)C(C)C(=O)NO"
        }
    },
    {
        "src_smiles": "COc1cc(C=C(C#N)c2ccccn2)ccc1OCc1ccccc1Cl",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a benzene ring with two methoxy groups (-OCH\u2083) and a chlorine substituent. It features a vinyl linkage (C=C) connected to both a nitrile group (-C\u2261N) and a pyridine ring, introducing additional aromatic character and electron-withdrawing functionalities.",
            "Property Analysis": "The molecule exhibits a high Quantitative Estimate of Drug-likeness (QED) due to its multiple aromatic systems and electron-withdrawing groups, which can enhance binding affinity and stability. However, the presence of bulky and lipophilic groups may negatively impact solubility and bioavailability.",
            "Limitation in Source Molecule for Property": "The high lipophilicity and molecular weight resulting from multiple aromatic rings and electron-withdrawing substituents may lead to poor aqueous solubility and reduced bioavailability. Additionally, the nitrile group can be metabolically unstable, potentially affecting the molecule's safety profile.",
            "Optimization for Source Molecule": "To improve QED, the molecule can be optimized by reducing lipophilicity and molecular weight. This can be achieved by replacing the nitrile group with a less lipophilic amide or ester, minimizing the number of aromatic rings, and introducing polar functional groups to enhance solubility. Additionally, substituting the chlorine with a less bulky halogen or removing it altogether may benefit the drug-likeness.",
            "Final Target Molecule": "COc1cc(C=CNC(=O)C2=CC=CC=N2)ccc1OCc1ccccc1Cl"
        }
    },
    {
        "src_smiles": "C=CCn1c(=O)c2[nH]c(Cc3ccc(N)cc3)nc2n(CCCC)c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a cinnamamide backbone with a pyrazine ring substituted by a phenethylamine moiety. It includes two ketone groups, multiple nitrogen atoms, and a butyl chain, contributing to its structural complexity.",
            "Property Analysis": "The molecule has a moderate QED score indicating drug-likeness, influenced by its aromatic rings, amine groups, and aliphatic chains, which affect properties like lipophilicity and hydrogen bonding.",
            "Limitation in Source Molecule for Property": "High molecular weight and extended alkyl chains increase lipophilicity and reduce solubility. Excessive hydrogen bond donors may hinder membrane permeability, negatively impacting the QED score.",
            "Optimization for Source Molecule": "Simplify the alkyl chains by reducing the butyl group to a methyl group, decrease the number of hydrogen bond donors by modifying amine groups, and streamline the molecular structure to enhance solubility and permeability.",
            "Final Target Molecule": "C=CCn1c(=O)c2[nH]c(Cc3ccncc3)nc2n(C)c1=O"
        }
    },
    {
        "src_smiles": "CCC1(CC)C(=O)N(COC(=O)c2ccccc2)C1S(=O)(=O)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a piperidine ring substituted with an n-propyl group, a sulfonyl group attached to a phenyl ring, and an amide linkage connecting to a methoxycarbonyl phenyl group. It features multiple aromatic rings, a sulfonyl functional group, an ester linkage, and amide functionalities, contributing to its overall complexity and structural rigidity.",
            "Property Analysis": "The molecule exhibits a moderate QED score, indicating a balanced drug-likeness. Key factors include its molecular weight, lipophilicity, hydrogen bond donors and acceptors, and structural complexity. The presence of multiple aromatic rings contributes to planarity and potential binding interactions, while functional groups like sulfonyl and ester may impact solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "The high number of aromatic rings increases molecular weight and lipophilicity, potentially reducing solubility and membrane permeability. Additionally, multiple hydrogen bond donors and acceptors may negatively affect oral bioavailability. The sulfonyl and ester groups might also pose metabolic liability, affecting the molecule\u2019s stability and longevity in biological systems.",
            "Optimization for Source Molecule": "To enhance the QED score, reduce molecular weight and lipophilicity by limiting the number of aromatic rings. Replace the sulfonyl-aryl group with a less bulky, more polar substituent to improve solubility without significantly affecting binding affinity. Modify the ester linkage to a more metabolically stable amide group. Introduce polar functional groups to maintain solubility while balancing lipophilicity for better membrane permeability.",
            "Final Target Molecule": "CCC1(CC)C(=O)N(CCOC(=O)Nc2ccccc2)C1CO"
        }
    },
    {
        "src_smiles": "Nc1ccc(-c2nnc(NC(=O)Nc3ccc(Cl)c(Cl)c3)s2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, Nc1ccc(-c2nnc(NC(=O)Nc3ccc(Cl)c(Cl)c3)s2)cc1, consists of an aniline moiety (a benzene ring substituted with an amino group) connected to a thiazole-like heterocycle. This heterocycle is further substituted with an amide linkage to a dichlorophenyl group. The molecule features multiple nitrogen atoms and chlorinated aromatic rings, contributing to its structural complexity.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) assesses the molecule's suitability as a drug candidate based on properties like molecular weight, lipophilicity (LogP), number of hydrogen bond donors and acceptors, and structural complexity. The source molecule's QED score reflects its balance between these factors, influencing its potential bioavailability and overall drug-like characteristics.",
            "Limitation in Source Molecule for Property": "The source molecule has several limitations that negatively impact its QED score. The presence of multiple chlorine atoms increases lipophilicity, which may reduce solubility and bioavailability. The molecule's high molecular weight and complex structure can hinder its ability to permeate biological membranes. Additionally, excessive hydrogen bond acceptors may lead to poor pharmacokinetic properties.",
            "Optimization for Source Molecule": "To improve the QED of the source molecule, the following optimizations are proposed: reduce the number of chlorine atoms to decrease lipophilicity, streamline the molecular structure to lower molecular weight and enhance permeability, and optimize hydrogen bond donors and acceptors to balance solubility and binding affinity. These modifications aim to create a more drug-like molecule with better pharmacokinetic properties.",
            "Final Target Molecule": "Nc1ccc(-c2nnc(NC(=O)Nc3ccccc3)s2)cc1"
        }
    },
    {
        "src_smiles": "COc1cc(N)c(C=Cc2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-]",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxy-substituted aniline ring connected via a vinyl linker to a tri-methoxy-substituted benzene ring and possesses a nitro group on the aniline nitrogen.",
            "Property Analysis": "The molecule exhibits high lipophilicity due to multiple methoxy groups and contains a nitro substituent, which may negatively impact its drug-likeness (QED).",
            "Limitation in Source Molecule for Property": "The presence of the nitro group and excessive methoxylation contribute to poor QED by increasing lipophilicity and potential toxicity.",
            "Optimization for Source Molecule": "Replace the nitro group with a less toxic amine and reduce the number of methoxy groups to decrease lipophilicity while maintaining necessary biological interactions.",
            "Final Target Molecule": "COc1cc(N)cc(C=Cc2cc(OC)c2)c1N"
        }
    },
    {
        "src_smiles": "Cc1ccc(SCCC(=O)Nc2ccc(OCc3ccccc3)cc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a tolyl ring linked via a sulfur atom to a propionamide moiety, which is further connected to a methoxy-substituted phenyl ring. It contains two aromatic rings, a thioether linkage, and an amide functional group.",
            "Property Analysis": "The molecule has a moderate QED score indicating reasonable drug-likeness. The presence of aromatic rings contributes to hydrophobicity, while the amide group provides some polarity.",
            "Limitation in Source Molecule for Property": "High molecular weight and multiple aromatic rings increase lipophilicity, potentially reducing solubility and bioavailability. The thioether linkage may also limit metabolic stability.",
            "Optimization for Source Molecule": "Reduce molecular weight by simplifying the aromatic system, replace the thioether with a more polar linker to enhance solubility, and introduce additional polar groups to improve overall drug-likeness.",
            "Final Target Molecule": "Cc1ccc(NC(=O)C(C)N)cc1Oc2ccccc2"
        }
    },
    {
        "src_smiles": "C=CCNC(=O)NC(=O)CN1C(=O)NC(c2ccccc2)(c2ccccc2)C1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a central pyrazine ring substituted with two phenyl groups. It contains multiple amide linkages and a vinyl group, resulting in a relatively rigid and planar structure with several hydrogen bond donors and acceptors.",
            "Property Analysis": "The molecule has moderate drug-likeness (QED) owing to its balanced lipophilicity and hydrogen bonding potential. However, the presence of multiple aromatic rings and amide groups contributes to higher molecular weight and increased polarity.",
            "Limitation in Source Molecule for Property": "High molecular weight and excessive hydrogen bond donors can reduce bioavailability and increase synthetic complexity. Additionally, increased polarity may limit the molecule's ability to permeate cell membranes effectively.",
            "Optimization for Source Molecule": "To enhance QED, reduce molecular weight by removing one phenyl group and modify amide linkages to decrease the number of hydrogen bond donors. Introducing a methyl group can also increase lipophilicity without significantly impacting polarity.",
            "Final Target Molecule": "C=CCNC(=O)N1C(=O)NC(c2ccccc2)C1=O"
        }
    },
    {
        "src_smiles": "O=C(CCCCCC(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a nitroso-substituted carbonyl group attached to a six-carbon aliphatic chain. At the termini of the chain, there are two fused aromatic rings containing nitrogen atoms, specifically imidazole-like structures. The molecule features multiple aromatic systems, an extensive carbon chain, and a nitroso functional group.",
            "Property Analysis": "The molecule exhibits a moderate quantitative estimate of drug-likeness (QED) due to its complex aromatic structures and functional groups that are favorable for biological interactions. However, certain structural features may negatively impact its overall drug-likeness.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic rings increases the molecular weight and lipophilicity, which can reduce solubility and permeability. The long aliphatic chain may contribute to poor pharmacokinetic properties, such as limited absorption. Additionally, the nitroso group may introduce potential toxicity concerns, further diminishing drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, the molecule can be optimized by reducing the length of the aliphatic chain to decrease molecular weight and lipophilicity. Simplifying the aromatic system by reducing the number of fused rings can enhance solubility and permeability. Replacing the nitroso group with a less toxic functional group, such as an amine, may improve safety and drug-likeness.",
            "Final Target Molecule": "O=C(CC(c1ccncc1)c1ccncc1)NH2"
        }
    },
    {
        "src_smiles": "Cc1ccc(NC(=O)C(=Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2ccccc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central toluene ring substituted with a bisamide linker. Each amide is connected to aromatic rings, one of which contains a nitro functional group. The structure features multiple aromatic systems, amide bonds, and a nitro group, contributing to its overall rigidity and potential for hydrogen bonding.",
            "Property Analysis": "The molecule has a high degree of aromaticity and multiple hydrogen bond acceptors due to the amide and nitro groups. These features contribute positively to the QED by enhancing solubility and molecular recognition capabilities. However, the presence of multiple aromatic rings and nitro groups may negatively impact drug-likeness by increasing molecular weight and lipophilicity.",
            "Limitation in Source Molecule for Property": "The high number of aromatic rings and the presence of a nitro group can lead to increased molecular weight and lipophilicity, which may reduce the QED. Additionally, nitro groups can be associated with toxicity and poor metabolic stability, further detracting from drug-likeness.",
            "Optimization for Source Molecule": "To improve the QED, the optimization process involves reducing the number of aromatic rings to decrease molecular weight and lipophilicity. Replacing the nitro group with a less electron-withdrawing and less toxic functional group can enhance metabolic stability and overall drug-likeness. Introducing polar heteroatoms or reducing rigidity may also contribute positively to the QED.",
            "Final Target Molecule": "Cc1ccc(NC(=O)C(=Cc2ccc(C(=O)O)cc2)NC(=O)c2ccccc2)cc1."
        }
    },
    {
        "src_smiles": "Cc1cc2c(c(=O)o1)C=C1CCC(C(C)CSc3ncccn3)CC1O2",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a benzofuran core fused with a cyclohexenone ring. It includes a methyl substituent on the benzene ring and a side chain comprising a thioether linkage connected to a triazole moiety. The structure is characterized by multiple fused rings and a combination of functional groups such as ether, ketone, thioether, and triazole.",
            "Property Analysis": "The molecule has a moderate QED score, indicating reasonable drug-likeness. It benefits from aromatic systems and heteroatoms that can enhance binding interactions. However, factors like high molecular weight, multiple ring systems, and the presence of potentially metabolically unstable groups may detract from its overall drug-like properties.",
            "Limitation in Source Molecule for Property": "The complexity and high molecular weight of the fused ring structures may negatively impact solubility and bioavailability. Additionally, the thioether and triazole groups could pose metabolic liabilities and reduce the molecule's overall drug-likeness by affecting its pharmacokinetic profile.",
            "Optimization for Source Molecule": "Simplify the molecular architecture by reducing ring complexity and molecular weight. Replace the thioether and triazole groups with more favorable functional groups that enhance solubility and metabolic stability. Introduce polar functional groups to improve hydrogen bonding without significantly increasing molecular size, thereby enhancing the QED score.",
            "Final Target Molecule": "Cc1cc2c(c(=O)o1)C=C1CCC(CC1O2)C(C)CO"
        }
    },
    {
        "src_smiles": "O=C1CC(N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C(=O)N1c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a bicyclic structure with a piperazine ring connected to a benzamide moiety. It contains two amide linkages, a nitro-substituted aromatic ring, and multiple nitrogen atoms, contributing to its overall polarity and potential hydrogen bonding capabilities.",
            "Property Analysis": "The molecule exhibits moderate QED (Quantitative Estimate of Drug-likeness) due to its balanced combination of hydrophilic and lipophilic properties. It has multiple hydrogen bond donors and acceptors, which can enhance its binding affinity. However, the presence of bulky nitro groups and high molecular weight slightly detracts from its drug-likeness.",
            "Limitation in Source Molecule for Property": "The nitro group present in the aromatic ring can reduce metabolic stability and increase potential toxicity, negatively impacting the QED. Additionally, the molecule's relatively high molecular weight may hinder its bioavailability and overall drug-likeness.",
            "Optimization for Source Molecule": "To improve the QED, the nitro group can be replaced with a less toxic and more metabolically stable substituent, such as a trifluoromethyl (CF\u2083) group. Reducing the molecular weight by simplifying the structure or removing bulky groups can enhance bioavailability. Additionally, optimizing the balance between hydrogen bond donors and acceptors can further improve drug-likeness.",
            "Final Target Molecule": "O=C1CC(N2CCN(c3ccc(C(F)(F)F)cc3)CC2)C(=O)N1c1ccccc1)"
        }
    },
    {
        "src_smiles": "COc1ccc(C=C(C)C(=O)c2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-]",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a 1,3-dimethoxybenzene core linked to a vinyl ketone moiety. This vinyl ketone is further connected to a 1,2,3-trimethoxyphenyl group and a nitro functional group. The molecule is characterized by multiple methoxy substituents and an electron-withdrawing nitro group, contributing to its overall lipophilicity and electron density.",
            "Property Analysis": "The molecule exhibits high lipophilicity due to multiple methoxy groups and the nitro group, which may affect its solubility and bioavailability. The presence of the nitro group can also influence the molecule's reactivity and potential toxicity, potentially lowering its QED score related to drug-likeness.",
            "Limitation in Source Molecule for Property": "High lipophilicity and the presence of a nitro group can negatively impact drug-likeness by reducing solubility and increasing potential toxicity. Additionally, multiple methoxy groups may contribute to metabolic instability and hinder oral bioavailability.",
            "Optimization for Source Molecule": "To enhance QED, reduce lipophilicity by decreasing the number of methoxy groups, replace the nitro group with a less toxic and more biocompatible substituent, and simplify the molecular structure to improve solubility and bioavailability.",
            "Final Target Molecule": "COc1ccc(C=C(C)C(=O)c2cc(OC)c2)cc1N"
        }
    },
    {
        "src_smiles": "COc1ccc(Cl)cc1C(=O)NCCc1ccc(CCC(=O)NO)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of two aromatic rings connected by a carbonyl-linked ethylene diamine chain. The first aromatic ring is substituted with a methoxy group and a chlorine atom, while the second aromatic ring is attached to a side chain containing a nitro group.",
            "Property Analysis": "The molecule exhibits high aromaticity, increased molecular weight, and multiple hydrogen bond donors and acceptors. These features contribute to its quantitative estimate of drug-likeness (QED) by affecting solubility and permeability.",
            "Limitation in Source Molecule for Property": "Excessive lipophilicity due to multiple aromatic rings and high molecular weight may negatively impact solubility and bioavailability. Additionally, the presence of multiple hydrogen bond donors and acceptors can reduce drug-likeness.",
            "Optimization for Source Molecule": "Simplify the molecular structure by reducing the number of aromatic rings and modifying or replacing certain functional groups to decrease lipophilicity and molecular weight while maintaining essential pharmacophore elements.",
            "Final Target Molecule": "COc1ccc(Cl)cc1C(=O)NCCc1ccc(C(=O)NO)cc1"
        }
    },
    {
        "src_smiles": "O=C(Oc1cc(O)c2c(c1)OC(c1ccc(O)cc1)CC2=O)c1cccs1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains multiple functional groups, including hydroxyl groups, carbonyl groups, ester linkages, and a thiochromane ring. It features a complex polycyclic structure with several aromatic rings, contributing to its molecular rigidity and potential for multiple hydrogen bonds.",
            "Property Analysis": "The molecule exhibits high lipophilicity due to multiple aromatic rings and ester groups, which may enhance membrane permeability but could also reduce aqueous solubility. The presence of hydroxyl groups allows for hydrogen bonding, potentially improving solubility and binding interactions. However, the overall molecular weight and complexity may negatively impact drug-likeness as assessed by QED.",
            "Limitation in Source Molecule for Property": "Excessive molecular complexity and high lipophilicity may lower the QED score by affecting solubility, bioavailability, and synthetic accessibility. The rigid polycyclic structure could limit conformational flexibility necessary for optimal binding to biological targets, and multiple ester linkages may be prone to metabolic hydrolysis.",
            "Optimization for Source Molecule": "Simplify the molecular structure by reducing the number of aromatic rings and ester linkages to decrease molecular weight and lipophilicity. Introduce polar functional groups to enhance aqueous solubility and maintain necessary hydrogen bonding capabilities. Optimize the ring structure to balance rigidity and flexibility, improving binding interactions and metabolic stability.",
            "Final Target Molecule": "O=C(Oc1ccc(O)cc1)C2CC(O)CC2"
        }
    },
    {
        "src_smiles": "Nc1cnc(-c2ccc(-c3ccccc3CSc3ccncn3)cc2F)cn1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a pyridine ring substituted with an amino group (Nc1cnc), a fluorophenyl group (-c2ccc(F)cc2), and a thiazole-linked biphenyl moiety (-c3ccccc3CS c3ccncn3). The molecule features multiple aromatic rings, heteroatoms (nitrogen and sulfur), and various functional groups that contribute to its complexity and potential biological activity.",
            "Property Analysis": "The molecule exhibits a high degree of aromaticity and multiple heteroatoms, which contribute positively to its drug-likeness (QED). However, the presence of bulky aromatic systems and sulfur-containing groups may affect its solubility and permeability. The overall molecular weight is moderately high, which is generally acceptable but could be optimized for better pharmacokinetic properties.",
            "Limitation in Source Molecule for Property": "The high aromaticity and presence of multiple bulky groups may lead to poor solubility and reduced bioavailability. Additionally, the sulfur-containing thiazole ring could introduce metabolic liabilities. The fluorine substituent, while beneficial for metabolic stability, may also increase lipophilicity excessively.",
            "Optimization for Source Molecule": "To improve QED, simplify the aromatic framework by reducing the number of aromatic rings to enhance solubility. Replace the thiazole-linked biphenyl moiety with a less bulky heterocycle to decrease molecular weight and improve permeability. Retain the fluorine substituent to maintain metabolic stability but consider its placement to balance lipophilicity.",
            "Final Target Molecule": "Nc1cnc(-c2ccc(F)cc2)cn1"
        }
    },
    {
        "src_smiles": "CCOc1ccccc1NS(=O)(=O)c1cc(-c2cnc(C3CC3)o2)ccc1C",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an ethoxy group attached to a phenyl ring, which is further connected to a sulfonamide linker. This sulfonamide is bonded to another phenyl ring that is substituted with a pyrimidine-fused heterocycle containing a cyclopropyl group and an oxygen atom.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness with a quantitative estimate of drug-likeness (QED) influenced by its balanced hydrophobic and hydrophilic regions. The presence of multiple aromatic rings and heterocycles contributes to its structural complexity, which may affect solubility and permeability.",
            "Limitation in Source Molecule for Property": "The rigidity introduced by the cyclopropyl group and multiple aromatic rings may reduce molecular flexibility, potentially impacting binding affinity and bioavailability. Additionally, the high degree of conjugation may lead to poor solubility, limiting its drug-likeness.",
            "Optimization for Source Molecule": "To enhance QED, introduce flexibility by replacing the cyclopropyl ring with a less rigid substituent such as a methyl or ethyl group. Reduce the number of aromatic rings to decrease molecular weight and increase solubility. Incorporate polar functional groups to improve aqueous solubility and bioavailability without compromising the molecule's stability.",
            "Final Target Molecule": "CCOc1ccccc1NS(=O)(=O)c1cc(-c2cnc(C)O2)ccc1C"
        }
    },
    {
        "src_smiles": "COc1ccc(C(=O)Nc2ccc(-c3nc4ncccc4[nH]3)cc2)cc1OC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a dimethoxyphenyl core substituted with an amide linkage connecting to a substituted benzene ring. Additionally, it contains a fused bicyclic system with multiple nitrogen atoms, including a triazole ring.",
            "Property Analysis": "The molecule exhibits moderate molecular weight, multiple hydrogen bond donors and acceptors, a relatively high logP value, and several aromatic and heteroaromatic rings, resulting in a QED score indicative of potential drug-likeness but with room for improvement.",
            "Limitation in Source Molecule for Property": "The presence of multiple heteroatoms and rigid bicyclic structures increases molecular complexity and hydrogen bond donors, which can negatively impact the QED score by violating drug-likeness rules such as Lipinski's Rule of Five.",
            "Optimization for Source Molecule": "Simplify the heterocyclic components by reducing the number of nitrogen atoms and fused rings, thereby decreasing molecular complexity and the number of hydrogen bond donors and acceptors. Introduce flexible linkers or replace rigid structures with more drug-like moieties to enhance QED.",
            "Final Target Molecule": "COc1ccc(C(=O)Nc2ccc(-c3ncncc3)cc2)cc1OC"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccnc(F)c1)c1ccc(-c2noc(C(F)(F)F)n2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an amide linked to a 2,1,3-benzoxadiazole core, which is further substituted with a trifluoromethyl group. The structure features multiple aromatic rings and fluorine atoms, contributing to its overall physicochemical properties.",
            "Property Analysis": "The molecule exhibits a moderate Quantitative Estimate of Drug-likeness (QED) score, suggesting a reasonable balance between hydrophilicity and lipophilicity. The presence of electron-withdrawing fluorine atoms may enhance binding affinity but can also impact solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "The high number of fluorine atoms increases lipophilicity, potentially reducing aqueous solubility and bioavailability. Additionally, multiple aromatic rings may lead to metabolic instability and off-target interactions, negatively affecting the QED score.",
            "Optimization for Source Molecule": "To improve QED, reduce the number of fluorine substituents to decrease lipophilicity and enhance solubility. Introduce polar functional groups or hydrogen bond donors/acceptors to increase aqueous solubility and metabolic stability. Simplify the aromatic system to reduce metabolic liabilities.",
            "Final Target Molecule": "O=C(Nc1ccnc(F)c1)c1ccc(-c2noc(C(F)F)n2)cc1"
        }
    },
    {
        "src_smiles": "O=C(CSc1cccc[n+]1[O-])Nc1ccccc1Oc1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises an amide linkage connecting a carbonyl group to a carbon atom bonded to a thioether and a benzothiazole moiety. Additionally, it features a nitrogen atom bonded to two aromatic rings through an ether linkage, specifically two phenyl groups connected via an oxygen atom.",
            "Property Analysis": "The molecule has a favorable quantitative estimate of drug-likeness (QED) due to its multiple aromatic rings and rigid structure, which can enhance binding affinity and specificity. However, the presence of charged nitrogen and extensive aromatic systems increase lipophilicity and molecular weight, which may negatively impact solubility and bioavailability.",
            "Limitation in Source Molecule for Property": "Key limitations affecting the QED property include high molecular weight, excessive lipophilicity, and the presence of a positive charge. These factors can lead to poor solubility, reduced bioavailability, and potential off-target interactions, which are detrimental to drug-like properties.",
            "Optimization for Source Molecule": "To enhance the QED, the molecule can be optimized by reducing molecular weight and lipophilicity. This involves neutralizing the positively charged nitrogen to improve solubility, simplifying the aromatic systems to decrease molecular complexity, and introducing polar functional groups to balance lipophilicity. Additionally, replacing some aromatic rings with heteroaromatic rings can enhance metabolic stability and reduce potential off-target effects.",
            "Final Target Molecule": "O=C(CS1C=NC=C1O)Nc1ccccc1Oc1ccccc1"
        }
    },
    {
        "src_smiles": "CCCCOC(=O)c1ccc(NC(=O)C2(c3cccs3)CCOCC2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a tetraethylene glycol ether linked to a benzamide moiety. The benzamide is further connected to a piperazine ring that contains a thioether bridge and an ethoxy substituent. The overall structure includes multiple functional groups such as ether, amide, thioether, and cyclic amine.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness with a reasonable balance of hydrophobic and hydrophilic properties. The presence of multiple rotatable bonds and polar functional groups may contribute positively to its solubility and membrane permeability. However, the thioether moiety and the extended alkyl chains might negatively impact its QED score by increasing molecular weight and lipophilicity.",
            "Limitation in Source Molecule for Property": "The primary limitations affecting the QED of the source molecule include its relatively high molecular weight, increased lipophilicity due to multiple alkyl chains, and the presence of the thioether group, which may reduce solubility and increase metabolic liability.",
            "Optimization for Source Molecule": "To enhance the QED, the molecule can be optimized by reducing molecular weight through shortening the alkyl chains, replacing the thioether with a more polar and metabolically stable group, and decreasing the number of rotatable bonds to improve rigidity. Additionally, introducing hydrogen bond donors or acceptors could enhance aqueous solubility without compromising membrane permeability.",
            "Final Target Molecule": "CCCOC(=O)c1ccc(NC(=O)C2NCCOCC2)cc1"
        }
    },
    {
        "src_smiles": "COC(=O)C1=C(C)N=C(C)C(=C(O)OC)C1c1ccc(Cl)c([N+](=O)[O-])c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxycarbonyl group attached to a central aromatic system. It features a substituted benzene ring with both chlorine and nitro groups. The molecule contains multiple conjugated double bonds and ester functionalities, contributing to its complex structure and potential interactions.",
            "Property Analysis": "The molecule exhibits a moderate QED score, indicating reasonable drug-likeness. It possesses a balanced combination of hydrophobic and hydrophilic groups, accessible functional sites for interactions, and an acceptable molecular weight. However, certain functional groups may detract from its overall drug-like properties.",
            "Limitation in Source Molecule for Property": "The presence of the nitro group is a significant limitation, as it can lead to increased toxicity and poor metabolic stability, negatively impacting the QED score. Additionally, the molecule may have a high number of rotatable bonds, which can reduce conformational stability and drug-likeness.",
            "Optimization for Source Molecule": "To enhance QED, the nitro group should be replaced with a less toxic and more metabolically stable functional group, such as an amino or hydroxyl group. Reducing the number of rotatable bonds by introducing rigid linkages or ring structures can improve conformational stability. Simplifying the molecular structure by removing or modifying bulky substituents may also contribute to better drug-like properties.",
            "Final Target Molecule": "COC(=O)C1=C(C)N=C(C)C(=C(O)OC)C1c1ccc(Cl)cc1"
        }
    },
    {
        "src_smiles": "CC(NC(=O)Nc1cc2[nH]nc(NC(C)c3ccccn3)c2cn1)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central piperazine ring bonded to multiple aromatic and heteroaromatic rings, including a quinazoline moiety. It features a urea linkage connecting to a benzyl group, and contains several nitrogen atoms within fused ring systems, contributing to its overall complexity and molecular weight.",
            "Property Analysis": "The molecule has a high molecular weight and significant lipophilicity, with multiple hydrogen bond donors and acceptors. These properties result in a moderate QED score, indicating potential challenges in solubility, bioavailability, and drug-likeness.",
            "Limitation in Source Molecule for Property": "The high lipophilicity and large size may adversely affect the molecule's solubility and oral bioavailability. Additionally, the presence of multiple hydrogen bond donors and acceptors can lead to poor selectivity and undesirable interactions, limiting its overall drug-likeness.",
            "Optimization for Source Molecule": "To enhance QED, the molecule can be simplified by reducing the number of aromatic and heteroaromatic rings to decrease molecular weight and lipophilicity. Introducing polar functional groups to improve solubility and reducing the number of hydrogen bond donors and acceptors can also enhance drug-likeness. Structural modifications should aim to maintain essential pharmacophoric features while optimizing physicochemical properties.",
            "Final Target Molecule": "CC(NC(=O)Nc1ccc2ncnc(NC(C)C)c2c1)c1ccccc1"
        }
    },
    {
        "src_smiles": "COc1ccc(NC(=O)COc2ccc(C(=O)Nc3cccc(F)c3)c3ccccc23)cc1OC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxy-substituted aromatic ring connected to an amide linkage. This amide is attached to a central ester moiety, which is further bonded to a fluorinated aromatic ring and a secondary aromatic system. The molecule exhibits multiple ether and amide functional groups, contributing to its overall complexity and rigidity.",
            "Property Analysis": "The molecule has a moderate QED score, indicating decent drug-likeness. Its aromatic systems and presence of fluorine atoms enhance lipophilicity and metabolic stability, while multiple oxygen and nitrogen atoms increase hydrogen bonding potential.",
            "Limitation in Source Molecule for Property": "The high number of aromatic rings and polar functional groups contribute to increased molecular weight and lipophilicity, which may adversely affect solubility and bioavailability. Additionally, the complexity of the molecule could lead to challenges in synthetic accessibility and potential off-target interactions.",
            "Optimization for Source Molecule": "To improve QED, simplify the aromatic framework by reducing the number of rings, introduce more polar but less bulky functional groups to enhance solubility, and decrease molecular weight. Replacing some ether linkages with bioisosteres could also improve metabolic stability without compromising activity.",
            "Final Target Molecule": "COc1cc(NC(=O)CClc2ccccc2)cc(O)c1OC"
        }
    },
    {
        "src_smiles": "Cc1cc(O)cc(C)c1CC(N)C(=O)N1Cc2ccccc2CC1C(=O)Nc1nn[nH]n1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of multiple aromatic rings, including a substituted benzyl alcohol moiety and a phenyl-piperidine ring system. It contains functional groups such as hydroxyl (-OH), amine (-NH), amide (C(=O)N), and a triazole ring, contributing to its complexity and potential for hydrogen bonding.",
            "Property Analysis": "The molecule exhibits characteristics that may enhance drug-likeness, such as aromatic rings which can facilitate binding interactions. However, it also has a high number of hydrogen bond donors and acceptors, and a relatively large molecular size, which may negatively impact properties like solubility and permeability, thereby affecting its QED score.",
            "Limitation in Source Molecule for Property": "The extensive number of hydrogen bond donors and acceptors, along with the molecule's large and complex structure, may result in poor oral bioavailability and reduced membrane permeability. Additionally, the high lipophilicity associated with multiple aromatic rings could lead to unfavorable pharmacokinetic properties.",
            "Optimization for Source Molecule": "To enhance the QED score, the molecule can be optimized by reducing the number of hydrogen bond donors and acceptors, simplifying the aromatic system, and decreasing molecular weight. This can be achieved by removing or modifying the triazole moiety, simplifying the piperidine ring, and reducing the number of hydroxyl groups to improve solubility and permeability.",
            "Final Target Molecule": "Cc1cc(O)cc(C)c1CC(N)C(=O)N1Cc2ccccc2CC1C=O"
        }
    },
    {
        "src_smiles": "CC(CCCNc1ccccc1)N(c1cc(Cl)ccc1CO)S(=O)(=O)c1ccc(Cl)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central sulfonamide group (S(=O)(=O)N) connected to three aromatic rings, two of which are chlorinated (4-chlorophenyl groups) and one hydroxylated (4-hydroxyphenyl group). It also features a side chain with a propyl linker attached to a benzylamine moiety.",
            "Property Analysis": "The molecule has a high QED score due to multiple aromatic rings and functional groups that enhance drug-like properties such as planarity and hydrogen bonding capabilities. However, the presence of multiple chlorine atoms increases lipophilicity and molecular weight, which can adversely affect solubility and bioavailability.",
            "Limitation in Source Molecule for Property": "The high number of chlorinated aromatic rings contribute to increased lipophilicity and molecular weight, potentially reducing solubility and drug-likeness. Additionally, the complex structure may hinder metabolic stability and increase the risk of off-target interactions.",
            "Optimization for Source Molecule": "To improve the QED property, chlorines were removed from the aromatic rings to decrease lipophilicity and molecular weight. The side chain was simplified to enhance solubility and reduce complexity, while maintaining essential functional groups for biological activity.",
            "Final Target Molecule": "CC(CCCNc1ccccc1)N(c1ccccc1CO)S(=O)(=O)c1ccccc1"
        }
    },
    {
        "src_smiles": "O=C(CCl)Nc1ccc(N2CCN(CC(O)(Cn3cncn3)c3ccc(F)cc3F)CC2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a chloromethyl ketone moiety connected to a benzene ring. This benzene ring is substituted with a piperazine ring, which is further linked to a triazole derivative and a difluorophenyl group. The molecule contains multiple nitrogen atoms, aromatic rings, and halogen substituents, contributing to its complex structure.",
            "Property Analysis": "The molecule exhibits drug-like properties with elements that support hydrogen bonding and molecular interactions. However, the presence of multiple aromatic rings and halogen atoms may increase lipophilicity and molecular weight, potentially affecting solubility and bioavailability negatively. The overall QED (Quantitative Estimate of Drug-likeness) may be moderate due to these factors.",
            "Limitation in Source Molecule for Property": "High lipophilicity and increased molecular weight due to multiple aromatic and halogenated groups may reduce the QED score. The complexity and rigidity of the structure could also limit favorable interactions with biological targets, potentially affecting the molecule's drug-likeness adversely.",
            "Optimization for Source Molecule": "To enhance QED, simplify the aromatic system by reducing the number of halogen substituents, which can lower lipophilicity and molecular weight. Introduce more polar functional groups to improve solubility and maintain essential hydrogen bonding capabilities. Additionally, streamline the molecular structure to increase flexibility, facilitating better interactions with biological targets.",
            "Final Target Molecule": "O=C(CCl)Nc1ccc(N2CCN(CC(O)C3ncnn3)CC2)cc1"
        }
    },
    {
        "src_smiles": "CC1=C(CC(=O)OCCCCO)c2cc(F)ccc2C1=Cc1ccc(S(C)(=O)=O)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a bicyclic core fused with two aromatic rings, one of which is fluorinated. It includes an ester-linked alcohol side chain and a sulfonamide functional group attached to an aromatic ring. The molecule has multiple functional groups that contribute to its complexity and polarity.",
            "Property Analysis": "The molecule exhibits moderate QED (drug-likeness) due to the presence of aromatic rings, fluorine substitution, and polar functional groups. These features enhance binding affinity and metabolic stability but may also increase molecular weight and polarity, potentially affecting bioavailability.",
            "Limitation in Source Molecule for Property": "The extended ester-alcohol side chain increases molecular weight and polarity, which can negatively impact membrane permeability and oral bioavailability. Additionally, the complexity of the fused ring system may pose challenges in synthetic accessibility.",
            "Optimization for Source Molecule": "To improve QED, the ester-alcohol side chain is shortened to reduce molecular weight and polarity. The sulfonamide group is retained for its favorable interaction properties, while simplifying the overall molecular structure to enhance bioavailability and synthetic accessibility.",
            "Final Target Molecule": "CC1=C(C(=O)OCC)c2cc(F)ccc2C1=Cc1ccc(S(=O)(=O)C)cc1"
        }
    },
    {
        "src_smiles": "Nc1cnc(-c2ccc(C3CCC3)c(OCC(O)CNc3cc(N)ncn3)c2F)cn1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a fused heterocyclic compound featuring a pyridine core (c1cnc...cn1). It contains multiple functional groups, including a fluorinated aromatic ring, a cyclohexyl moiety (C3CCC3), an ether linkage (OCC), a secondary alcohol (O), and a substituted amine nitrogen (Nc3cc(N)ncn3). The molecule also incorporates an imidazole ring with various substituents that contribute to its complexity and three-dimensional structure.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) for the source molecule suggests moderate drug-like properties. The presence of multiple functional groups can enhance solubility and binding interactions, while the fluorine atom may improve metabolic stability. However, the molecule's complexity and potential for multiple hydrogen bond donors and acceptors could affect its drug-likeness adversely.",
            "Limitation in Source Molecule for Property": "The source molecule exhibits high molecular complexity and a relatively large number of rotatable bonds, which may negatively impact its QED by reducing bioavailability and increasing synthetic difficulty. Additionally, the presence of multiple nitrogen-containing heterocycles can increase polarity, potentially hindering cell membrane permeability.",
            "Optimization for Source Molecule": "To enhance the QED, structural simplification is proposed by reducing the number of rotatable bonds and decreasing molecular complexity. This can be achieved by removing or merging certain functional groups, such as the cyclohexyl moiety, and replacing it with a more rigid, less flexible substituent. Additionally, modifying the number of nitrogen atoms in the heterocycles to balance polarity and lipophilicity can improve drug-likeness.",
            "Final Target Molecule": "Nc1cnc(-c2ccc(C3CNC3)c(OCC(O)CNc3cc(N)ncn3)c2F)cn1"
        }
    },
    {
        "src_smiles": "COc1cccc(C(=O)Nc2ccc(-c3ccc(S(=O)(=O)NC(C(=O)O)C(C)C)cc3)cc2)c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features an anisole (methoxyphenyl) moiety connected to an amide linkage, which is further attached to a sulfonamide-substituted aromatic ring. Additionally, it includes a bulky tert-butyl ester group, introducing significant steric hindrance and multiple functional groups that may impact its pharmacokinetic properties.",
            "Property Analysis": "The molecule exhibits high molecular weight, increased lipophilicity, and a high number of hydrogen bond donors and acceptors. These characteristics contribute to a lower QED (Quantitative Estimate of Drug-likeness) score, potentially affecting its bioavailability and overall drug-like properties.",
            "Limitation in Source Molecule for Property": "Excessive molecular weight, high lipophilicity, and the presence of bulky substituents (tert-butyl ester) reduce the drug-likeness of the source molecule by negatively impacting solubility and membrane permeability.",
            "Optimization for Source Molecule": "Simplify the molecular structure by replacing the bulky tert-butyl ester with a smaller ester group, reducing the number of hydrogen bond donors/acceptors by modifying the sulfonamide linkage, and decreasing overall molecular weight to enhance QED and improve drug-like properties.",
            "Final Target Molecule": "COc1ccccc1C(=O)NC2ccccc2S(=O)(=O)NC(C(=O)O)C"
        }
    },
    {
        "src_smiles": "NS(=O)(=O)c1ccc(Nc2nccc(-c3ccc(NC(=O)Cc4cccs4)cc3)n2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a sulfonamide group attached to a phenyl ring, which is further connected to a fused heterocyclic system containing nitrogen atoms and a thioether linkage. The molecule includes multiple aromatic rings and functional groups that contribute to its overall structure and complexity.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness with a QED score influenced by its molecular weight, number of hydrogen bond donors and acceptors, lipophilicity, and structural complexity. The presence of multiple aromatic and heteroaromatic rings may enhance binding interactions but also increase molecular rigidity.",
            "Limitation in Source Molecule for Property": "High molecular weight and increased number of rotatable bonds may negatively impact the molecule's oral bioavailability and solubility. Additionally, the presence of a thioether linkage can reduce metabolic stability.",
            "Optimization for Source Molecule": "Simplify the molecular framework by reducing the number of aromatic rings, replacing the thioether linkage with a more metabolically stable amide or ether group, and decreasing the number of rotatable bonds to enhance flexibility and solubility. Introduce polar functional groups to improve solubility without significantly increasing molecular weight.",
            "Final Target Molecule": "NS(=O)(=O)c1ccc(Nc2nccc(-c3ccccc3)cc2)cc1"
        }
    },
    {
        "src_smiles": "Cc1oc(=O)oc1COC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of multiple ester linkages (\u2013OC(=O)O\u2013), methoxy groups (\u2013OCH\u2083), and aromatic rings substituted with chlorine atoms. It features a cyclic structure with fused heterocycles, including two lactone (dioxolane) rings. The molecule also contains bulky tert-butyl groups which contribute to its overall steric complexity.",
            "Property Analysis": "The molecule exhibits high polarity due to numerous ester and ether groups, which can enhance solubility but may adversely affect membrane permeability. The presence of aromatic rings and halogen substituents like chlorine can improve binding affinity and metabolic stability. However, the overall complexity and high number of polar functional groups may reduce its Quantitative Estimate of Drug-likeness (QED) by increasing molecular weight and decreasing lipophilicity.",
            "Limitation in Source Molecule for Property": "The excessive number of polar ester and ether linkages increases molecular polarity, negatively impacting lipophilicity and membrane permeability, which are critical for drug-likeness. Additionally, the bulky tert-butyl groups and multiple aromatic rings contribute to a high molecular weight, limiting the molecule's drug-like properties according to Lipinski's rules.",
            "Optimization for Source Molecule": "To enhance QED, reduce molecular polarity by replacing some ester and ether linkages with less polar functional groups such as alkyl chains or amines. Simplify the aromatic system by removing or substituting the chlorine atoms with smaller substituents to decrease steric hindrance and molecular weight. Consider replacing bulky tert-butyl groups with smaller alkyl groups to improve lipophilicity while maintaining essential interactions for biological activity.",
            "Final Target Molecule": "CCOC(=O)OCCOC1ccc(C(=O)c2ccccc2)cc1"
        }
    },
    {
        "src_smiles": "Cc1c(NC(=O)c2ccc(S(=O)(=O)Nc3ccccc3F)cc2)c(=O)n(-c2ccccc2)n1C",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a pyrimidine core substituted with methyl groups, an amide linkage to a benzene ring containing a sulfonamide group connected to a fluorinated benzene ring. The structure includes multiple aromatic rings and functional groups such as amides and sulfonamides, contributing to its complexity and molecular weight.",
            "Property Analysis": "The molecule has a relatively high molecular weight and significant lipophilicity due to multiple aromatic systems and functional groups. It possesses several hydrogen bond donors and acceptors, which can impact its solubility and permeability, key factors in drug-likeness as measured by QED.",
            "Limitation in Source Molecule for Property": "The high number of aromatic rings and functional groups increases lipophilicity and molecular size, which may negatively affect the QED score by reducing solubility and increasing the complexity of the molecule, potentially leading to poor pharmacokinetic properties.",
            "Optimization for Source Molecule": "Simplify the molecular structure by reducing the number of aromatic rings and replacing highly lipophilic groups with more balanced alternatives. Specifically, remove the fluorinated benzene ring and modify the sulfonamide group to enhance solubility and lower lipophilicity, thereby improving the overall QED.",
            "Final Target Molecule": "Cc1c(NC(=O)c2ccc(S(=O)(=O)N)cc2)c(=O)n(-c2ccccc2)n1C"
        }
    },
    {
        "src_smiles": "CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2cc([N+](=O)[O-])cn2C)CC1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a piperazine ring substituted with a fluorinated aromatic system, multiple amide linkages, and nitro groups. It features a complex fused ring structure with electron-withdrawing groups that contribute to its overall polarity.",
            "Property Analysis": "The molecule exhibits high polarity and multiple hydrogen bond donors and acceptors due to the presence of amide and nitro groups. The fluorinated aromatic rings contribute to its lipophilicity. These factors collectively influence the QED (drug-likeness) by balancing solubility and membrane permeability.",
            "Limitation in Source Molecule for Property": "The presence of multiple nitro groups increases molecular polarity excessively, potentially reducing membrane permeability and oral bioavailability. Additionally, the high number of aromatic rings may lead to increased lipophilicity, which can negatively impact solubility and lead to aggregation issues.",
            "Optimization for Source Molecule": "To improve QED, reduce the number of nitro groups by replacing them with less polar functionalities such as amino groups. Simplify the aromatic system to decrease lipophilicity while maintaining essential interactions. Introduce polar but non-ionizable groups to enhance solubility without compromising permeability.",
            "Final Target Molecule": "CN1CCN(C2=CC3=C(C=C2F)C(=O)CN3C)CC1"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccccc1C(=O)N1CCOCC1)c1ccc(CSc2ccccc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains multiple functional groups, including amide bonds, a thiophene ring, and ethylene glycol moieties. The structure features a central amide linkage connecting a phenyl group to a bicyclic amine system. Additionally, there is a thiophene-substituted phenyl ring, which imparts aromaticity and potential \u03c0-\u03c0 interactions.",
            "Property Analysis": "The molecule exhibits moderate drug-likeness with a QED score that reflects its balance between hydrophilic and lipophilic properties. The presence of multiple aromatic rings and amide bonds contributes to its binding affinity and specificity. However, the molecule's complexity may affect its solubility and permeability, which are critical factors in drug design.",
            "Limitation in Source Molecule for Property": "The primary limitations affecting the QED of the source molecule include its relatively high molecular weight and the presence of multiple aromatic and heteroaromatic rings. These features can lead to poor solubility and reduced bioavailability. Additionally, the molecule's rigidity due to multiple ring systems may limit its conformational flexibility, potentially impacting its ability to interact with diverse biological targets.",
            "Optimization for Source Molecule": "To enhance the QED of the molecule, structural modifications can be made to reduce molecular weight and increase solubility. This can be achieved by replacing one of the aromatic rings with a less lipophilic heterocycle, such as a pyridine or thiazole ring. Introducing polar functional groups, like hydroxyl groups, can also improve solubility. Furthermore, simplifying the bicyclic amine system may increase conformational flexibility, enhancing the molecule's ability to interact with various targets.",
            "Final Target Molecule": "O=C(Nc1ccccc1C(=O)N1C(=O)CCOCC1)c1ccc(CSc2ncccc2)cc1"
        }
    },
    {
        "src_smiles": "CN(C(=O)c1ccc(-c2nc(C3CCOCC3)cnc2N)cc1F)C(CO)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a central nitrogen atom bonded to two distinct moieties. One side consists of an acetylated phenyl ring substituted with a fluorine atom and a heterocyclic system containing a dioxane ring fused to a pyrimidine-like structure. The other side comprises a benzyl alcohol group attached to a phenyl ring.",
            "Property Analysis": "The molecule has a moderate QED (Quantitative Estimate of Drug-likeness) score, influenced by its aromatic rings, heterocyclic structures, and the presence of fluorine atoms. These features contribute to its potential biological activity but also affect its drug-like properties.",
            "Limitation in Source Molecule for Property": "The high molecular weight, increased lipophilicity from multiple aromatic and fluorinated rings, and the complexity of the heterocyclic system negatively impact the QED. These factors may lead to poor solubility, reduced bioavailability, and challenges in synthesis.",
            "Optimization for Source Molecule": "To enhance QED, the molecule can be optimized by reducing molecular weight through the removal or simplification of aromatic rings, decreasing lipophilicity by minimizing fluorine substitutions, and streamlining the heterocyclic components to improve solubility and bioavailability.",
            "Final Target Molecule": "CN(C(=O)c1ccccc1)C(CO)c1ccccc1"
        }
    },
    {
        "src_smiles": "CC(Sc1ncccn1)C(=O)Nc1ncc(Cc2cccc3ccccc23)s1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an ethyl thioether group connected to a pyridine ring, which is further attached to a carbonyl-linked nitrogen connected to another pyridine ring substituted with a multi-fused aromatic system including a thiazole moiety.",
            "Property Analysis": "The molecule has a high Quantitative Estimate of Drug-likeness (QED) due to its aromatic rings, appropriate molecular weight, and presence of functional groups favorable for drug-like properties.",
            "Limitation in Source Molecule for Property": "The complexity of the fused aromatic system may hinder synthetic accessibility and metabolic stability. Additionally, the high number of aromatic rings could lead to poor solubility and increased lipophilicity beyond optimal drug-like ranges.",
            "Optimization for Source Molecule": "Simplify the aromatic framework by reducing the number of fused rings, replace the thioether linkage with a more metabolically stable amine bond, and adjust substituents to balance lipophilicity, enhancing solubility and overall drug-likeness.",
            "Final Target Molecule": "CCN(Cc1ncccn1)C(=O)Nc1nccs1"
        }
    },
    {
        "src_smiles": "CCCCOC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a butoxy ester linked to a carbonyl group, which connects to a complex fused heterocyclic system containing chlorine and methoxy substituents. The structure includes a bicyclic ring system with multiple nitrogen atoms, contributing to its overall complexity.",
            "Property Analysis": "The molecule exhibits a moderate QED (Quantitative Estimate of Drug-likeness) score, indicating reasonable drug-like properties. It possesses multiple heteroatoms and functional groups that may facilitate interactions with biological targets. However, the extended alkyl chain and halogen substituent may impact its solubility and pharmacokinetic profile.",
            "Limitation in Source Molecule for Property": "The presence of a long butoxy chain increases lipophilicity, which may reduce solubility and increase off-target interactions. Additionally, the chlorine atom contributes to higher molecular weight and lipophilicity, potentially leading to poor bioavailability and increased metabolic liabilities.",
            "Optimization for Source Molecule": "To enhance the QED score, the molecule can be optimized by shortening the alkyl chain to improve solubility and reduce lipophilicity. Replacing the chlorine substituent with a less lipophilic group, such as a methyl or hydroxyl group, may enhance drug-like properties. Additionally, simplifying the heterocyclic system could reduce molecular complexity and improve pharmacokinetic profiles.",
            "Final Target Molecule": "CCOC(=O)CC1N=C(c2ccc(C)cc2)c2cc(OC)ccc2-n2c(C)nnc21"
        }
    },
    {
        "src_smiles": "Cc1cc(C#N)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2Cc2cc(N)nc(F)c2F)c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a substituted benzene ring with a methyl group and a nitrile group. It features a complex fused ring system containing multiple carbonyl groups, a hydrazone linkage, and fluorine substituents, contributing to its rigidity and complexity.",
            "Property Analysis": "The molecule may exhibit moderate QED due to its size and the presence of multiple functional groups. The lipophilicity is elevated by the methyl and fluorine groups, while hydrogen bond donors and acceptors are present through carbonyl and nitrile functionalities.",
            "Limitation in Source Molecule for Property": "High molecular weight and excessive functionalization, including multiple fluorine and nitrile groups, can negatively impact drug-likeness. The rigidity from the fused ring system may also reduce bioavailability and Flexibility needed for target binding.",
            "Optimization for Source Molecule": "Simplify the molecular structure by reducing the number of rings and removing less favorable functional groups such as nitrile and excessive fluorination. Introduce more polar groups to improve solubility and maintain essential interactions for biological activity. Aim to decrease molecular weight and increase flexibility to enhance QED.",
            "Final Target Molecule": "Cc1cc(C)cc(C(=O)c2c(C)C)c1"
        }
    },
    {
        "src_smiles": "O=C(C=Cc1ccco1)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains multiple amide linkages connecting phenyl rings and a cinnamoyl group with a furan ring. It has a relatively high molecular weight and multiple aromatic systems, contributing to its rigidity and potential lipophilicity.",
            "Property Analysis": "The molecule exhibits a moderate QED value, indicating reasonable drug-likeness. It has several hydrogen bond donors and acceptors, significant lipophilicity, and a high number of rotatable bonds, which may affect its bioavailability and solubility.",
            "Limitation in Source Molecule for Property": "High molecular weight and excessive lipophilicity may reduce bioavailability and increase metabolic burden. The presence of multiple aromatic rings can lead to poor solubility and limited permeability, negatively impacting overall drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, the structure can be simplified by reducing the number of aromatic rings, introducing polar functional groups to enhance solubility, and decreasing molecular weight by modifying or removing non-essential moieties. Additionally, reducing rotatable bonds can improve molecular rigidity and bioavailability.",
            "Final Target Molecule": "O=C(C=Cc1ccco1)NC(Cc1ccccc1)C(=O)O"
        }
    },
    {
        "src_smiles": "CC(C)C(NS(=O)(=O)c1ccc(-c2ccc(COc3cccc(F)c3)cc2)cc1)C(=O)O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an isopropyl group attached to a sulfonamide moiety. The sulfonamide is connected to a benzene ring substituted with a fluorinated methoxyphenyl group and a carboxylic acid. The molecule features multiple functional groups including sulfonamide, ether, aromatic rings, and a carboxylic acid, contributing to its complexity and potential interactions in a biological context.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) assesses the molecule's drug-like properties based on factors such as molecular weight, lipophilicity, solubility, and the presence of functional groups commonly found in successful drugs. The current QED value reflects a balance between hydrophobic and hydrophilic regions, hydrogen bond donors and acceptors, and overall molecular complexity, which are critical for bioavailability and efficacy.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic rings and the sulfonamide group contribute to increased molecular weight and lipophilicity, which may adversely affect solubility and permeability. Additionally, the fluorinated methoxyphenyl group, while enhancing metabolic stability, can increase the molecule's polarity, potentially reducing membrane permeability and oral bioavailability. These factors collectively may lower the overall QED score by making the molecule less drug-like.",
            "Optimization for Source Molecule": "To improve the QED, structural modifications should aim to reduce molecular weight and lipophilicity while maintaining key functional groups essential for biological activity. Introducing polar but non-protic groups can enhance solubility without significantly impacting permeability. Reducing the number of aromatic rings or replacing them with less lipophilic bioisosteres can also contribute to a better balance of drug-like properties. Additionally, modifying the sulfonamide group to a less polar amide might enhance membrane permeability.",
            "Final Target Molecule": "CC(C)C(NC(=O)c1ccc(-c2ccc(COc3ccc(F)cc3)cc2)cc1)C(=O)O"
        }
    },
    {
        "src_smiles": "Cc1ccc(NC(=O)CN2C(=O)SC(=Cc3ccc(-c4ccc(Cl)c(C(=O)O)c4)o3)C2=O)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a para-substituted toluene core linked to a urea moiety. This urea is connected to a thioester group, which is further attached to a complex polycyclic structure featuring multiple aromatic rings, including a chlorinated benzene ring and a carboxylic acid-functionalized phenyl ring.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) assesses the drug-likeness based on properties like molecular weight, lipophilicity, solubility, and the presence of specific functional groups. The source molecule has a moderate QED score due to its complexity and multiple aromatic systems, which may affect solubility and bioavailability.",
            "Limitation in Source Molecule for Property": "The high number of aromatic rings and the presence of halogen substituents (chlorine) increase lipophilicity, potentially reducing solubility and increasing the risk of off-target interactions. Additionally, the molecular weight is relatively high, which may impede cell membrane permeability and oral bioavailability.",
            "Optimization for Source Molecule": "To improve the QED score, the molecule can be simplified by reducing the number of aromatic rings to decrease lipophilicity. Introducing polar functional groups can enhance solubility. Replacing the chlorine atom with a less lipophilic substituent and reducing the overall molecular weight by removing or modifying bulky groups are also recommended.",
            "Final Target Molecule": "Cc1ccc(NC(=O)CN2C(=O)SC(=CC3=CC=C(O)C=C3)C2=O)cc1O"
        }
    },
    {
        "src_smiles": "CNC(=O)N(C)CC(O)CN1C2CCC1CC(NC(=O)c1cc3ccccc3n(C(C)C)c1=O)C2",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains multiple amide linkages, a secondary alcohol, and a complex bicyclic structure with a substituted benzoxazine ring. It features nitrogen heteroatoms and several ring systems, contributing to its structural complexity and potential for extensive hydrogen bonding.",
            "Property Analysis": "The molecule exhibits a moderate QED score, indicating reasonable drug-likeness. Factors such as its molecular weight, number of hydrogen bond donors and acceptors, and lipophilicity are within acceptable ranges but leave room for optimization to enhance its drug-like properties.",
            "Limitation in Source Molecule for Property": "The high number of hydrogen bond donors and acceptors, along with the molecule's structural complexity, may negatively impact its bioavailability and increase the potential for off-target interactions, thereby limiting its overall drug-likeness.",
            "Optimization for Source Molecule": "Simplify the molecular structure by reducing the number of hydrogen bond donors and acceptors, remove or modify bulky substituents to lower molecular weight, and adjust functional groups to enhance lipophilicity, thereby improving the QED score.",
            "Final Target Molecule": "CNC(=O)N(C)CC(O)CN1C2CCC1CC(NC(=O)c1cc3ccccc3n(C)c1=O)C2"
        }
    }
]